# EDGAR Filing Document

**Accession Number:** 0001879373
**File Stem:** 0001493152-23-001534
**Filing Date:** 2023-1
**Character Count:** 160585
**Document Hash:** 7cb86f8382e6c24b7dd8a3689a0cbdad
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-001534.hdr.sgml**: 20230117

**ACCESSION NUMBER**: 0001493152-23-001534

**CONFORMED SUBMISSION TYPE**: 425

**PUBLIC DOCUMENT COUNT**: 4

**FILED AS OF DATE**: 20230117

**DATE AS OF CHANGE**: 20230117

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Energem Corp
- **CENTRAL INDEX KEY:** 0001879373
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRICAL INDUSTRIAL APPARATUS [3620]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** N8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 425
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41070
- **FILM NUMBER:** 23530378

**BUSINESS ADDRESS:**
- **STREET 1:** LEVEL 10, TOWER 11 SANICHI, AVENUE 5
- **STREET 2:** NO. 8, JALAN KERINCHI, BANGSAR SOUTH
- **CITY:** WILAYAHPERSEKUTUANKUALA LUMPUR
- **STATE:** N8
- **ZIP:** 59200
- **BUSINESS PHONE:** 60327047622

**MAIL ADDRESS:**
- **STREET 1:** LEVEL 10, TOWER 11 SANICHI, AVENUE 5
- **STREET 2:** NO. 8, JALAN KERINCHI, BANGSAR SOUTH
- **CITY:** WILAYAHPERSEKUTUANKUALA LUMPUR
- **STATE:** N8
- **ZIP:** 59200
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Energem Corp
- **CENTRAL INDEX KEY:** 0001879373
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRICAL INDUSTRIAL APPARATUS [3620]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** N8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 425

**BUSINESS ADDRESS:**
- **STREET 1:** LEVEL 10, TOWER 11 SANICHI, AVENUE 5
- **STREET 2:** NO. 8, JALAN KERINCHI, BANGSAR SOUTH
- **CITY:** WILAYAHPERSEKUTUANKUALA LUMPUR
- **STATE:** N8
- **ZIP:** 59200
- **BUSINESS PHONE:** 60327047622

**MAIL ADDRESS:**
- **STREET 1:** LEVEL 10, TOWER 11 SANICHI, AVENUE 5
- **STREET 2:** NO. 8, JALAN KERINCHI, BANGSAR SOUTH
- **CITY:** WILAYAHPERSEKUTUANKUALA LUMPUR
- **STATE:** N8
- **ZIP:** 59200

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

CURRENT REPORT

Pursuant to Section 13 or 15(d) of<br> the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): **January 12, 2023**

**Energem Corp.**

(Exact name of registrant as specified in its charter)

**Cayman Islands**

(State or other jurisdiction of incorporation)

---

| | |
|:---|:---|
| **001-41070** | **N/A** |
| (Commission<br> File Number) | (IRS Employer<br> Identification No.) |

---

**Level 3, Tower 11, Avenue 5, No. 8, Jalan Kerinchi , Bangsar South**

**Wilayah Persekutuan Kuala Lumpur, Malaysia 59200**

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code **+(60) 3270 47622**

**N/A**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☒ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of Each Class** | **Trading Symbol(s)** | **Name of Each Exchange on Which Registered** |
| Units, each consisting of one Class A ordinary share, par value $0.0001 per share, and one redeemable warrant | ENCPU | The Nasdaq Stock Market LLC |
| Class A ordinary shares included as part of the units | ENCP | The Nasdaq Stock Market LLC |
| Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 | ENCPW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

*Energem Corp., a Cayman Islands exempted company ("**Energem**"), initially filed with the U.S. Securities and Exchange Commission (the "**SEC**") on December 7, 2022, a registration statement on Form F-4 (File No. 333-268716) (as may be amended by a Form S-4 from time to time, the "**Registration Statement**"), which includes a preliminary proxy statement of Energem, and a prospectus in connection with the proposed business combination transaction (the "**Business Combination**") involving Energem and Graphjet Technology Sdn. Bhd., a Malaysian private limited company ("**Graphjet**"). Promptly after the Form S-4 is declared effective by the SEC, the definitive proxy statement and other relevant documents will be mailed to securityholders of Energem as of a record date to be established for a special meeting to be held to approve the Business Combination. Securityholders of Energem and other interested persons are advised to read, when available, the preliminary proxy statement/prospectus, and amendments thereto, and the definitive proxy statement/prospectus in connection with Energem's solicitation of proxies for the special meeting to be held to approve the Business Combination because these documents will contain important information about Energem, Graphjet and the Business Combination. Energem securityholders and other interested persons will also be able to obtain copies of the Registration Statement and the proxy statement/prospectus, without charge, once available, on the SEC's website at sec.gov or by directing a request to: Energem Corp., Level 3, Tower 11, Avenue 5, No. 8, Jalan Kerinchi, Bangsar South, Wilayah Persekutuan Kuala Lumpur, Malaysia.*

**Item 1.01. Entry into a Material Definitive Agreement.**

***Standby Equity Purchase Agreement***

On January 12, 2023, Energem, Graphjet and YA II PN, Ltd., a Cayman Islands exempt limited partnership managed by Yorkville Advisors Global, LP (the "**Investor**") entered into a Standby Equity Purchase Agreement (the "**SEPA**"). The Investor is a fund headquartered in Mountainside, New Jersey.

Upon the closing of the Business Combination, the combined entity, Graphjet Technology (the "**Company**") will have the right to issue and sell to the Investor, from time to time, as provided in the SEPA, and the Investor shall purchase from the Company, up to $200 million in aggregate gross purchase price (the "**Commitment Amount**") of the newly issued shares of the Company's Class A Ordinary Shares (the "**Ordinary Shares**") (each such sale, an "**Advance**") by delivering written notice to the Investor (each, an "**Advance Notice**" and the date on which the Company is deemed to have delivered an Advance Notice, the "**Advance Notice Date**"). The Ordinary Shares purchased pursuant to an Advance will be purchased at a price equal to 96% of volume-weighted average price during a one day pricing period or 97% of the three-day volume-weighted average price during a three-day pricing period elected by Graphjet Technology.

The Company shall, in its sole discretion, select the amount of the Advance that it desires to issue and sell to the Investor in each Advance Notice, not to exceed the greater of (i) an amount equal to 100% of the average of the Daily Traded Amount during the five consecutive Trading Days immediately preceding an Advance Notice, or (ii) one million Ordinary Shares (the "**Maximum Advance Amount**").

For purposes of determining the Maximum Advance Amount, "Daily Traded Value" shall mean the product obtained by multiplying the daily trading volume of the Ordinary Shares on Nasdaq during regular trading hours as reported by Bloomberg L.P., by the VWAP for such trading day. There shall be no mandatory minimum of Advances under the SEPA. "**VWAP**" means, for any trading day, the daily volume weighted average price of the Ordinary Shares for such trading day on Nasdaq during regular trading hours as reported by Bloomberg L.P.

The Company may not issue or sell any Ordinary Shares to the Investor under the SEPA which, when aggregated with all other Ordinary Shares beneficially owned by the Investor and its affiliates (as calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and Rule 13d-3 promulgated thereunder), would result in the Investor and its affiliates beneficially owning more than 9.99% of the outstanding Ordinary Shares (the "**Beneficial Ownership Limitation**"). The Beneficial Ownership Limitation may be waived by the Investor as to itself and its affiliates, on the terms and subject to the conditions set forth in the SEPA.

Pursuant to the terms of the SEPA, the Company shall prepare and file with the Securities and Exchange Commission (the "**SEC**") a registration statement (the "**Registration Statement**") or multiple Registration Statements registering for resale the Ordinary Shares issuable to the Investor under the SEPA. The Company in its sole discretion may choose when to file such Registration Statements; provided, however, that the Company shall not have the ability to request any Advances until the effectiveness of a Registration Statement.

As consideration for the Investor's commitment to purchase Ordinary Shares at the Company's direction upon the terms and subject to the conditions set forth in the SEPA, the Company will issue 200,000 Ordinary Shares to the Investor.

The SEPA shall terminate automatically on the earliest of (i) the first day of the month next following the 36-month anniversary of the sixth trading day following the date of closing of the Business Combination, (ii) the date on which the Investor shall have made payment of Ordinary Shares pursuant to the SEPA for Ordinary Shares equal to the Commitment Amount, and (iii) the termination of the Share Purchase Agreement. The SEPA may be terminated at any time by the mutual written consent of the parties to the SEPA, effective as of the date of such mutual written consent unless otherwise provided in such written consent, or by Energem upon five trading days' prior written notice to the Investor subject to the terms of the SEPA.

This section describes the material provisions of the SEPA but does not purport to describe all of the terms thereof. The summary herein is qualified in its entirety by reference to the complete text of the SEPA, a copy of which is attached hereto as Exhibit 2.1. Energem's securityholders and other interested parties are urged to read such agreement in its entirety. Unless otherwise defined herein, the capitalized terms used below are defined in the SEPA.

**Item 3.02. Unregistered Sales of Equity Securities**.

The information contained above in Item 1.01 is hereby incorporated by reference into this Item 3.02. In the SEPA, the Investor represented that, among other things, it is an institutional "accredited investor" as defined in Rule 501(a)(3) of Regulation D under the Securities Act of 1933, as amended (the "**Securities Act**"). The securities referred to in this Current Report on Form 8-K are being issued and sold by the Company to the Investor in reliance upon the exemption from the registration requirements of the Securities Act afforded by Section 4(a)(2) of the Securities Act.

**Item 7.01. Regulation FD Disclosure.**

On January 17, 2023, Energem issued a press release announcing the execution of the SEPA. The press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.

The information in this Item 7.01, including Exhibit 99.1, is being furnished and will not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "**Exchange Act**"), or otherwise be subject to the liabilities of that section, nor will it be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act.

**Item 8.01.** **Other Events.**

On November 18, 2021, Energem consummated its initial public offering (the "IPO"). In connection therewith, Energem entered into an Investment Management Trust Agreement, dated November 18, 2021, by and between Energem and Continental Stock Transfer & Trust Company, as trustee ("**Continental**") (the "**Trust Agreement**"). A form of the Trust Agreement was initially filed as an exhibit to Energem's Registration Statement on Form S-1 (File No. 333-259443) in connection with the IPO.

As previously announced on Form 8-K on November 18, 2022, on November 16, 2022, at 9:00 a.m. ET, Energem held an extraordinary general meeting of its shareholders pursuant to due notice (the "**Extraordinary General Meeting**"). Energem shareholders entitled to vote at the Extraordinary General Meeting cast their votes and approved an amendment to the Trust Agreement (the "**Trust Amendment Proposal**"), pursuant to which the Trust Agreement was amended to extend the date on which Continental must liquidate the Trust Account established in connection with the IPO (the "**Trust Account**") if Energem has not completed its initial business combination, from November 18, 2022 to August 18, 2023 provided Energem deposits $0.045 per Energem public Class A ordinary share per month extended.

Shareholders of Energem also approved the Second Amended and Restated Articles of Association of Energem at the Extraordinary General Meeting, giving Energem the right to extend the date by which Energem must (i) consummate a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination involving Energem and one or more businesses (a "**business combination**"), (ii) cease its operations if it fails to complete such business combination, and (iii) redeem or repurchase 100% of Energem's Class A ordinary shares included as part of the units sold in Energem's IPO from November 18, 2022 (the "**Termination Date")** by up to nine (9) one-month extensions to August 18, 2023 (the "**Extension Amendment Proposal**").

In connection with the voting on the Extension Amendment Proposal and the Trust Amendment Proposal at the Extraordinary General Meeting, holders of 9,604,519 shares of Energem's Class A ordinary shares exercised their right to redeem those shares for cash at an approximate price of $10.21 per share, for an aggregate of approximately $98,062,138.99. Following the payment of the redemptions, the Trust Account had a balance of approximately $19,360,390.01.

 ****

***Deposit of Extension Funds***

In connection with the third monthly extension of the Termination Date, Energem caused $0.045 per outstanding share of Energem's Class A ordinary shares or approximately $85,296.45 for 1,895,481 Class A ordinary shares to be paid to the Trust Account on January 13, 2022 in advance of the January 18, 2022 due date.

**Important Information About the Proposed Business Combination and Where to Find It**

Energem has filed a registration statement on Form F-4 with the SEC, which will include a proxy statement/prospectus, and will file other documents regarding the proposed transaction with the SEC. Energem's shareholders and other interested persons are advised to read, when available, the preliminary proxy statement/prospectus and the amendments thereto and the definitive proxy statement and documents incorporated by reference therein filed in connection with the proposed business combination, as these materials will contain important information about Graphjet and Energem and the proposed business combination. Promptly after the Form F-4 is declared effective by the SEC, Energem will mail the definitive proxy statement/prospectus and a proxy card to each shareholder entitled to vote at the meeting relating to the approval of the business combination and other proposals set forth in the proxy statement/prospectus. **Before making any voting or investment decision, investors and shareholders of Energem are urged to carefully read the entire registration statement and proxy statement/prospectus, when they become available, and any other relevant documents filed with the SEC, as well as any amendments or supplements to these documents, because they will contain important information about the proposed transaction**. The documents filed by Energem with the SEC may be obtained free of charge at the SEC's website at www.sec.gov, or by directing a request to Energem Corp., Level 3, Tower 11, Avenue 5, No. 8, Jalan Kerinchi, Bangsar South, Wilayah Persekutuan, Kuala Lumpur, Malaysia.

**No Offer or Solicitation**

This Current Report on Form 8-K is for informational purposes only and is not intended to and shall not constitute a proxy statement or the solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Business Combination or PIPE financing and is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy or subscribe for any securities or a solicitation of any vote of approval, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

**Participants in Solicitation**

Energem Corp. and certain of its directors, executive officers and other members of management and employees may, under SEC rules, be deemed to be participants in the solicitation of proxies from Energem's shareholders in connection with the proposed transaction. A list of the names of those directors and executive officers and a description of their interests in Energem will be included in the proxy statement/prospectus for the proposed business combination when available at www.sec.gov. Information about Energem's directors and executive officers and their ownership of Energem ordinary shares is set forth in Energem's final prospectus dated November 15, 2021 and filed with the SEC on November 17, 2021, as modified or supplemented by any Form 3 or Form 4 filed with the SEC since the date of such filing. Other information regarding the interests of the participants in the proxy solicitation will be included in the proxy statement/prospectus pertaining to the proposed business combination when it becomes available. These documents can be obtained free of charge from the source indicated above.

Graphjet Technology Sdn. Bhd. and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the shareholders of Energem in connection with the proposed business combination. A list of the names of such directors and executive officers and information regarding their interests in the proposed business combination will be included in the proxy statement/prospectus for the proposed business combination.

Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests is included in the proxy statement/prospectus filed with the SEC on Form F-4. Shareholders, potential investors and other interested persons should read the proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from the sources indicated above.

**Cautionary Statement Regarding Forward-Looking Statements**

This Current Report on Form 8-K contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results, our plans, objectives, expectations and intentions with respect to future operations, products and services; and other statements identified by words such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "believe," "intend," "plan," "projection," "outlook" or words of similar meaning. These forward-looking statements include, but are not limited to, statements regarding Graphjet's industry and market sizes, future opportunities for Energem and Graphjet, Energem and Graphjet's estimated future results and the transactions contemplated by the Share Purchase Agreement, including the implied enterprise value, the expected transaction and ownership structure and the likelihood and ability of the parties to successfully consummate the transactions contemplated by the Share Purchase Agreement. Such forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements.

In addition to factors previously disclosed in Energem's reports filed with the SEC and those identified elsewhere in this communication, the following factors, among others, could cause actual results and the timing of events to differ materially from the anticipated results or other expectations expressed in the forward-looking statements: (i) the risk that the transactions contemplated by the Share Purchase Agreement may not be completed in a timely manner or at all, which may adversely affect the price of Energem's securities; (ii) the risk that the transactions contemplated by the Share Purchase Agreement may not be completed by Energem's Business Combination deadline and the potential failure to obtain an extension of the Business Combination deadline if sought by Energem; (iii) the failure to satisfy the conditions to the consummation of the transactions contemplated by the Share Purchase Agreement, including the adoption of the Share Purchase Agreement by the shareholders of Energem, the satisfaction of the minimum cash amount following redemptions by Energem's public shareholders and the receipt of certain governmental and regulatory approvals; (iv) the lack of a track record for Graphjet to determine the market's reaction to its technology; (v) the occurrence of any event, change or other circumstance that could give rise to the termination of the Share Purchase Agreement; (vi) the effect of the announcement or pendency of the transactions contemplated by the Share Purchase Agreement on Graphjet's business relationships, performance and business generally; (vii) risks that the transactions contemplated by the Share Purchase Agreement disrupt current plans and operations of Graphjet; (viii) the outcome of any legal proceedings that may be instituted against Graphjet or Energem related to the Share Purchase Agreement or the transactions contemplated thereby; (ix) the ability to maintain the listing of Energem's securities on Nasdaq Global Market; (x) the price of Energem's securities, including following the Closing, may be volatile due to a variety of factors, including changes in the competitive and regulated industries in which Graphjet operates, variations in performance across competitors, changes in laws and regulations affecting Graphjet's business and changes in the capital structure; (xi) the ability to implement business plans, forecasts, and other expectations after the completion of the transactions contemplated by the Share Purchase Agreement, and identify and realize additional opportunities; (xii) the risk of downturns and the possibility of rapid change in the highly competitive industry in which Graphjet operates, and the risk of changes in applicable law, rules, regulations and regulatory guidance that could adversely impact Graphjet's operations; (xiii) the risk that Graphjet and its current and future collaborators are unable to successfully develop and commercialize Graphjet's products or services, or experience significant delays in doing so; (xiv) the risk that Graphjet may not achieve or sustain profitability; (xv) the risk that Graphjet will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; and (xvi) the risk that Graphjet experiences difficulties in managing its growth and expanding operations.

Actual results, performance or achievements may differ materially, and potentially adversely, from any projections and forward-looking statements and the assumptions on which those forward-looking statements are based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as projected financial information and other information are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond our control. All information set forth herein speaks only as of the date hereof in the case of information about Energem and Graphjet or the date of such information in the case of information from persons other than Energem or Graphjet, and we disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this communication. Forecasts and estimates regarding Graphjet's industry and end markets are based on sources we believe to be reliable, however there can be no assurance these forecasts and estimates will prove accurate in whole or in part. Annualized, pro forma, projected, and estimated numbers are used for illustrative purpose only, are not forecasts and may not reflect actual results.

**Item 9.01.** **Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| Exhibit No. | Description |
| 2.1 | [Standby Equity Purchase Agreement](ex2-1.htm) |
| 99.1 | [Press Release](ex99-1.htm) |
| 104 | Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit). |

---

**<u>SIGNATURES</u>**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, Energem Corp. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **ENERGEM CORP.** | **ENERGEM CORP.** |
| Date: January 17, 2023 | By: | */s/ Swee Guan Hoo* |
|  | Name: | Swee Guan Hoo |
|  | Title: | Chief Executive Officer |

---

## Exhibit 2.1

**Exhibit 2.1**

**<u>STANDBY EQUITY PURCHASE AGREEMENT</u>**

**THIS STANDBY EQUITY PURCHASE AGREEMENT** (this "<u>Agreement</u>") dated as of January 12, 2023 is made by and among **YA II PN, LTD.**, a Cayman Islands exempt limited partnership (the "<u>Investor</u>"), **Energem Corp.,** a company incorporated under the laws of the Cayman Islands (the "<u>Company</u>") and Graphjet Technology Sdn. Bhd., a Malaysian private limited company ("<u>Graphjet</u>").

**WHEREAS**, the parties desire that, upon the terms and subject to the conditions contained herein, the Company, upon the closing of the Business Combination (as defined below) shall have the right to issue and sell to the Investor, from time to time as provided herein, and the Investor shall purchase from the Company, up to $200 million in aggregate gross purchase price of the newly issued shares of the Company's Class A Ordinary Shares (the "<u>Ordinary Shares</u>; and

**WHEREAS**, upon the closing of the Business Combination, the Company will acquire all of the issued and outstanding shares of Graphjet and the Company will change its name to Graphjet Technology;

**WHEREAS**, the offer and sale of the Ordinary Shares issuable hereunder will be made in reliance upon Section 4(a)(2) under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (the "<u>Securities Act</u>"), or upon such other exemption from the registration requirements of the Securities Act as may be available with respect to any or all of the transactions to be made hereunder; and

**WHEREAS**, in consideration of the Investor's execution and delivery of this Agreement, the Company shall issue to the Investor the Commitment Shares pursuant to and in accordance with Section 12.04.

**NOW**, **THEREFORE**, the parties hereto agree as follows:

**Article I. Certain Definitions**

"<u>Additional Shares</u>" shall have the meaning set forth in Section 2.01(d)(ii).

"<u>Adjusted Advance Amount</u>" shall have the meaning set forth in Section 2.01(d)(ii) .

"<u>Advance</u>" shall mean any issuance and sale of Advance Shares by the Company to the Investor pursuant to Article II hereof.

"<u>Advance Date</u>" shall mean the first Trading Day after expiration of the applicable Pricing Period for each Advance.

"<u>Advance Notice</u>" shall mean a written notice in the form of Exhibit A attached hereto to the Investor executed by an officer of the Company and setting forth the number of Advance Shares that the Company desires to issue and sell to the Investor.

"<u>Advance Notice Date</u>" shall mean each date the Company is deemed to have delivered (in accordance with Section 2.01(b) of this Agreement) an Advance Notice to the Investor, subject to the terms of this Agreement.

"<u>Advance Shares</u>" shall mean the Ordinary Shares that the Company shall issue and sell to the Investor pursuant to the terms of this Agreement.

"<u>Affiliate</u>" shall have the meaning set forth in Section 3.07.

"<u>Agreement</u>" shall have the meaning set forth in the preamble of this Agreement.

"<u>Applicable Laws</u>" shall mean all applicable laws, statutes, rules, regulations, orders, executive orders, directives, policies, guidelines and codes having the force of law, whether local, national, or international, as amended from time to time, including without limitation (i) all applicable laws that relate to money laundering, terrorist financing, financial record keeping and reporting, (ii) all applicable laws that relate to anti-bribery, anti-corruption, books and records and internal controls, including the United States Foreign Corrupt Practices Act of 1977, and (iii) any Sanctions laws.

"<u>Average Price</u>" shall mean a price per Share (rounded to the nearest tenth of a cent) equal to the quotient obtained by dividing (i) the aggregate gross purchase price paid by the Investor for all Shares purchased pursuant to this Agreement, by (ii) the aggregate number of Shares issued pursuant to this Agreement.

"<u>Black Out Period</u>" shall have the meaning set forth in Section 6.01(e).

"<u>Business Combination</u>" shall mean the transactions contemplated by the Share Purchase Agreement, dated August 1, 2022 (the "<u>Share Purchase Agreement</u>"), by and among the Company, Graphjet, and the other parties thereto, whereby (i) the Company will acquire all of the issued and outstanding shares of Graphjet, and (ii) the Company will change its name to Graphjet Technology.

"<u>Closing</u>" shall have the meaning set forth in Section 2.02.

"<u>Commitment Amount</u>" shall mean $200,000,000 of Ordinary Shares.

"<u>Commitment Shares</u>" shall have the meaning set forth in Section 12.04.

"<u>Commitment Period</u>" shall mean the period commencing on the Effective Date and expiring upon the date of termination of this Agreement in accordance with Section 10.01.

"<u>Company</u>" shall have the meaning set forth in the preamble of this Agreement.

"<u>Company Indemnitees</u>" shall have the meaning set forth in Section 5.02.

"<u>Condition Satisfaction Date</u>" shall have the meaning set forth in Section 7.01.

"<u>Daily Traded Amount</u>" shall mean the daily trading volume of the Company's Ordinary Shares on the Principal Market during regular trading hours as reported by Bloomberg L.P.

"<u>Effective Date</u>" shall mean the sixth Trading Day following the date of closing of the Business Combination.

"<u>Environmental Laws</u>" shall have the meaning set forth in Section 4.13.

"<u>Exchange Act</u>" shall mean the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

"<u>Exchange Cap</u>" shall have the meaning set forth in Section 2.01(c)(iii).

"<u>Excluded Day</u>" shall have the meaning set forth in Section 2.01(d)(i).

"<u>Hazardous Materials</u>" shall have the meaning set forth in Section 4.13.

"<u>Indemnified Liabilities</u>" shall have the meaning set forth in Section 5.01.

"<u>Investor</u>" shall have the meaning set forth in the preamble of this Agreement.

"<u>Investor Indemnitees</u>" shall have the meaning set forth in Section 5.01.

"<u>Market Price</u>" shall mean an Option 1 Market Price or Option 2 Market Price, as applicable.

"<u>Material Adverse Effect</u>" shall mean any event, occurrence or condition that has had or would reasonably be expected to have (i) a material adverse effect on the legality, validity or enforceability of this Agreement or the transactions contemplated herein, (ii) a material adverse effect on the operations, assets, business, earnings, properties, prospects, stockholder's equity, results of operations, or condition (financial or otherwise) of the Company and its Subsidiaries, taken as a whole, or prevent or materially interfere with consummation of the transactions contemplated hereby, or (iii) a material adverse effect on the Company's ability to perform in any material respect on a timely basis its obligations under this Agreement.

"<u>Material Outside Event</u>" shall have the meaning set forth in Section 6.08.

"<u>Maximum Advance Amount</u>" in respect of each Advance Notice means the greater of: (i) an amount equal to 100% of the average of the Daily Traded Amount during the five consecutive Trading Days immediately preceding an Advance Notice, or (ii) one million Ordinary Shares.

"<u>Minimum Acceptable Price</u>" or "<u>MAP</u>" shall mean the minimum price notified by the Company to the Investor in each Advance Notice, if applicable.

"<u>OFAC</u>" shall have the meaning set forth in Section 4.28.

"<u>Option 1 Market Price</u>" shall mean the VWAP of the Ordinary Shares during the Option 1 Pricing Period.

"<u>Option 2 Market Price</u>" shall mean the lowest daily VWAP of the Ordinary Shares during the Option 2 Pricing Period.

"<u>Option 1 Pricing Period</u>" shall mean the period on the applicable Advance Notice Date with respect to an Advance Notice selecting an Option 1 Pricing Period commencing upon receipt by the Company of written confirmation (which may be by e-mail) of acceptance of such Advance Notice by the Investor (or the open of regular trading hours, if later), and which confirmation shall specify such commencement time, and ending on 4:00 p.m. New York City time on the applicable Advance Notice Date.

"<u>Option 2 Pricing Period</u>" shall mean the three consecutive Trading Days commencing on the Advance Notice Date.

"<u>Ordinary Shares</u>" shall have the meaning set forth in the recitals of this Agreement.

"<u>Ownership Limitation</u>" shall have the meaning set forth in Section 2.01(c)(i).

"<u>Person</u>" shall mean an individual, a corporation, a partnership, a limited liability company, a trust or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof.

"<u>Plan of Distribution</u>" shall mean the section of a Registration Statement disclosing the plan of distribution of the Shares.

"<u>Pricing Period</u>" shall mean the Option 1 Pricing Period or Option 2 Pricing Period, as applicable.

"<u>Principal Market</u>" shall mean the Nasdaq Stock Market; provided however, that in the event the Company's Ordinary Shares are ever listed or traded on another national exchange, then the "Principal Market" shall mean such other market or exchange on which the Company's Ordinary Shares are then listed or traded to the extent such other market or exchange is the principal trading market or exchange for the Ordinary Shares.

"<u>Prospectus</u>" shall mean any prospectus (including, without limitation, all amendments and supplements thereto) used by the Company in connection with a Registration Statement.

"<u>Prospectus Supplement</u>" shall mean any prospectus supplement to a Prospectus filed with the SEC from time to time pursuant to Rule 424(b) under the Securities Act, including the documents incorporated by reference therein, including, without limitation, any prospectus supplement to be filed in accordance with Section 6.01 hereof.

"<u>Purchase Price</u>" shall mean the price per Advance Share obtained by multiplying the Market Price by (i) 96% in respect of an Advance Notice with an Option 1 Pricing Period, and (ii) 97% in respect of an Advance Notice with an Option 2 Pricing Period.

"<u>Registrable Securities</u>" shall mean (i) the Shares, and (ii) any securities issued or issuable with respect to any of the foregoing by way of exchange, stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization or otherwise.

"<u>Registration Limitation</u>" shall have the meaning set forth in Section 2.01(c)(ii).

"<u>Registration Statement</u>" shall mean a registration statement on Form S-1 or Form S-3 or on such other form promulgated by the SEC for which the Company then qualifies and which counsel for the Company shall deem appropriate, and which form shall be available for the registration of the resale by the Investor of the Registrable Securities under the Securities Act, which registration statement provides for the resale from time to time of the Shares as provided herein.

"<u>Regulation D</u>" shall mean the provisions of Regulation D promulgated under the Securities Act.

"<u>Sanctions</u>" shall have the meaning set forth in Section 4.28.

"<u>Sanctioned Countries</u>" shall have the meaning set forth in Section 4.28.

"<u>SEC</u>" shall mean the U.S. Securities and Exchange Commission.

"<u>SEC Documents</u>" shall have the meaning set forth in Section 4.05.

"<u>Securities Act</u>" shall have the meaning set forth in the recitals of this Agreement.

"<u>Settlement Document</u>" shall have the meaning set forth in Section 2.02(a).

"<u>Shares</u>" shall mean the Commitment Shares and the Ordinary Shares to be issued from time to time hereunder pursuant to an Advance.

"<u>Subsidiaries</u>" shall mean any Person in which the Company, directly or indirectly, (x) owns a majority of the outstanding capital stock or holds a majority of the equity or similar interest of such Person or (y) controls or operates all or substantially all of the business, operations or administration of such Person, and the foregoing are collectively referred to herein as "<u>Subsidiaries</u>."

"<u>Trading Day</u>" shall mean any day during which the Principal Market shall be open for business.

"<u>Transaction Documents</u>" shall have the meaning set forth in Section 4.02.

"<u>Volume Threshold</u>" shall mean a number of Ordinary Shares equal to the quotient of (a) the number of Advance Shares requested by the Company in an Advance Notice divided by (b) 0.20.

"<u>VWAP</u>" shall mean for any Trading Day, the daily volume weighted average price of the Ordinary Shares for such Trading Day on the Principal Market during regular trading hours (or such other period in the case of an Option 1 Pricing Period) as reported by Bloomberg L.P through its "AQR" function. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period.

**Article II. Advances**

Section 2.01 <u>Advances; Mechanics</u>. Upon the terms and subject to the conditions of this Agreement, during the Commitment Period, the Company, at its sole discretion, shall have the right, but not the obligation, to issue and sell to the Investor, and the Investor shall purchase from the Company, Advance Shares by the delivery to the Investor of Advance Notices on the following terms:

&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Advance Notice</u>. At any time during the Commitment Period the Company may require the Investor
 to purchase Shares by delivering an Advance Notice to the Investor, subject to the satisfaction
 or waiver by the Investor of the conditions set forth in Section 7.01, and in accordance
 with the following provisions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The
 Company shall, in its sole discretion, select the number of Advance Shares, not to exceed
 the Maximum Advance Amount, it desires to issue and sell to the Investor in each Advance
 Notice and the time it desires to deliver each Advance Notice, and the Pricing Period to
 be used.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) There
 shall be no mandatory minimum Advances and no non-usages fee for not utilizing the Commitment
 Amount or any part thereof.

&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Date of Delivery of Advance Notice</u>. Advance Notices shall be delivered in accordance with
 the instructions set forth on the bottom of <u>Exhibit A</u> attached hereto. An Advance
 Notice selecting an Option 1 Pricing Period shall only be delivered on a Trading Day and
 shall be deemed delivered on the day such notice is received by e-mail. An Advance Notice
 selecting an Option 2 Pricing Period shall be deemed delivered on (i) the day it is received
 by the Investor if such notice is received by e-mail at or before 8:30 a.m. New York City
 time (or at such later time if agreed to by the Investor in its sole discretion) in accordance
 with the instructions set forth on the bottom of <u>Exhibit A</u> attached hereto, or (ii)
 the immediately succeeding day if it is received by e-mail after 8:30 a.m. New York City
 time. Upon receipt of an Advance Notice, the Investor shall promptly (and, with respect to
 an Advance Notice selecting an Option 1 Pricing Period, in no event more than one-half hour
 after receipt) provide written confirmation (which may be by e-mail) of receipt of such Advance
 Notice, and which confirmation, in the case of an Advance Notice selecting an Option 1 Pricing
 Period, shall specify the commencement time of the Option 1 Pricing Period.

&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Advance Limitations</u>. Regardless of the number of Advance Shares requested by the Company in the
 Advance Notice, the final number of Shares to be issued and sold pursuant to an Advance Notice
 shall be reduced (if at all) in accordance with each of the following limitations:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Ownership Limitation; Commitment Amount</u>. At the request of the Company, the Investor shall inform
 the Company of the amount of shares the Investor beneficially owns. Notwithstanding anything
 to the contrary contained in this Agreement, the Investor shall not be obligated to purchase
 or acquire, and shall not purchase or acquire, any Ordinary Shares under this Agreement which,
 when aggregated with all other Ordinary Shares beneficially owned by the Investor and its
 affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated
 thereunder), would result in the beneficial ownership by the Investor and its affiliates
 (on an aggregated basis) to exceed 9.99% of the outstanding voting power or number of Ordinary
 Shares (the " <u>Ownership Limitation</u> "). Upon the written request of the Investor,
 the Company shall promptly (but no later than the next business day on which the transfer
 agent for the Ordinary Shares is open for business) confirm orally or in writing to the Investor
 the number of Ordinary Shares then outstanding. In connection with each Advance Notice delivered
 by the Company, any portion of the number of Advance Shares that would (i) cause the Investor
 to exceed the Ownership Limitation or (ii) cause the aggregate number of Shares issued and
 sold to the Investor hereunder to exceed the Commitment Amount shall automatically be withdrawn
 with no further action required by the Company, and such Advance Notice shall be deemed automatically
 modified to reduce the number of Advance Shares requested by an amount equal to such withdrawn
 portion; *provided that* in the event of any such automatic withdrawal and automatic
 modification, the Investor will promptly notify the Company of such event.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) <u>Registration Limitation</u>. In no event shall an Advance exceed the amount registered in respect of the
 transactions contemplated hereby under the Registration Statement then in effect (the " <u>Registration Limitation</u> "). In connection with each Advance Notice, any portion of an Advance
 that would exceed the Registration Limitation shall automatically be withdrawn with no further
 action required by the Company and such Advance Notice shall be deemed automatically modified
 to reduce the aggregate amount of the requested Advance by an amount equal to such withdrawn
 portion; provided that in the event of any such automatic withdrawal and automatic modification,
 the Investor will promptly notify the Company of such event.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) <u>Exchange Cap</u>. Notwithstanding anything to the contrary herein, the Company shall not effect any
 sales under this Agreement and the Investor shall not have the obligation to purchase Common
 Shares under this Agreement to the extent (but only to the extent) that after giving effect
 to such purchase and sale the aggregate number of Common Shares issued under this Agreement
 would exceed 19.99% of the aggregate amount of Common Shares issued and outstanding as of
 the date of this Agreement (the " <u>Exchange Cap</u> ") *provided that,* the
 Exchange Cap will not apply if (a) the Company's stockholders have approved issuances
 in excess of the Exchange Cap in accordance with the rules of the Principal Market, or (b)
 the Average Price of all applicable sales of Common Shares hereunder (including any sales
 covered by an Advance Notice that has been delivered prior to the determination of whether
 this clause (b) applies) equals or exceeds the lower of (i)
 the Nasdaq Official Closing Price (as reflected on Nasdaq.com) immediately preceding the
 Effective Date; or (ii) the average Nasdaq Official Closing Price for the five Trading Days
 immediately preceding the Effective Date). In connection with each Advance Notice,
 any portion of an Advance that would exceed the Exchange Cap shall automatically be withdrawn
 with no further action required by the Company and such Advance Notice shall be deemed automatically
 modified to reduce the aggregate amount of the requested Advance by an amount equal to such
 withdrawn portion in respect of each Advance Notice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) <u>Volume Threshold</u>. In connection with an Advance Notice, if the total number of Ordinary Shares
 traded on the Principal Market during the applicable Pricing Period is less than the Volume
 Threshold, then the number of Advance Shares issued and sold pursuant to such Advance Notice
 shall be reduced to the greater of (a) 20% of the trading volume of the Company's Ordinary
 Shares on the Principal Market during the Pricing Period as reported by Bloomberg L.P., or
 (b) the number of Ordinary Shares sold by the Investor during such Pricing Period, but not
 to exceed the amount requested in the Advance Notice.

&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Minimum Acceptable Price</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) With
 respect to each Advance Notice selecting an Option 2 Pricing Period, the Company may notify
 the Investor of the MAP with respect to such Advance by indicating a MAP on such Advance
 Notice. If no MAP is specified in an Advance Notice, then no MAP shall be in effect in connection
 with such Advance. Each Trading Day during an Option 2 Pricing Period for which (A) with
 respect to each Advance Notice with a MAP, the VWAP of the Ordinary Shares is below the MAP
 in effect with respect to such Advance Notice, or (B) there is no VWAP (each such day, an
 " <u>Excluded Day</u> "), shall result in an automatic reduction to the number
 of Advance Shares set forth in such Advance Notice by one-third (the resulting amount of
 each Advance being the " <u>Adjusted Advance Amount</u> "), and each Excluded Day
 shall be excluded from the Option 2 Pricing Period for purposes of determining the Market
 Price.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) The
 total Advance Shares in respect of each Advance (after reductions have been made to arrive
 at the Adjusted Advance Amount, if any) shall be automatically increased by such number of
 Ordinary Shares (the " <u>Additional Shares</u> ") equal to the number of Ordinary
 Shares sold by the Investor on such Excluded Day, if any, and the price paid per share for
 each Additional Share shall be equal to the MAP in effect with respect to such Advance Notice
 multiplied by 97%, provided that this increase shall not cause the total Advance Shares to
 exceed the amount set forth in the original Advance Notice or any limitations set forth in
 Section 2.01(c).

&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Unconditional Contract</u>. Notwithstanding any other provision in this Agreement, the Company and the
 Investor acknowledge and agree that upon the Investor's receipt of a valid Advance
 Notice the parties shall be deemed to have entered into an unconditional contract binding
 on both parties for the purchase and sale of Advance Shares pursuant to such Advance Notice
 in accordance with the terms of this Agreement and subject to Applicable Laws and (ii) subject
 to Section 3.08, the Investor may sell Ordinary Shares during the Pricing Period.

Section 2.02 <u>Closings</u>. The closing of each Advance and each sale and purchase of Advance Shares (each, a "<u>Closing</u>") shall take place as soon as practicable on or after each Advance Date in accordance with the procedures set forth below. The parties acknowledge that the Purchase Price is not known at the time the Advance Notice is delivered (at which time the Investor is irrevocably bound) but shall be determined on each Closing based on the daily prices of the Ordinary Shares that are the inputs to the determination of the Purchase Price as set forth further below. In connection with each Closing, the Company and the Investor shall fulfill each of its obligations as set forth below:

&nbsp;&nbsp;&nbsp;&nbsp;(a) On
 each Advance Date, the Investor shall deliver to the Company a written document, in the form
 attached hereto as Exhibit B (each a " <u>Settlement Document</u> "), setting forth
 the final number of Shares to be purchased by the Investor (taking into account any adjustments
 pursuant to <u>Section 2.01</u>), the Market Price, the Purchase Price, the aggregate proceeds
 to be paid by the Investor to the Company, and a report by Bloomberg, L.P. indicating the
 VWAP for each of the Trading Days during the Pricing Period (or, if not reported on Bloomberg,
 L.P., another reporting service reasonably agreed to by the parties), in each case in accordance
 with the terms and conditions of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;(b) Promptly
 after receipt of the Settlement Document with respect to each Advance (and, in any event,
 not later than one Trading Day after such receipt), the Company will, or will cause its transfer
 agent to, electronically transfer such number of Advance Shares to be purchased by the Investor
 (as set forth in the Settlement Document) by crediting the Investor's account or its
 designee's account at the Depository Trust Company through its Deposit Withdrawal at
 Custodian System or by such other means of delivery as may be mutually agreed upon by the
 parties hereto, and transmit notification to the Investor that such share transfer has been
 requested. Promptly upon receipt of such notification, the Investor shall pay to the Company
 the aggregate purchase price of the Shares (as set forth in the Settlement Document) in cash
 in immediately available funds to an account designated by the Company in writing and transmit
 notification to the Company that such funds transfer has been requested. No fractional shares
 shall be issued, and any fractional amounts shall be rounded to the next higher whole number
 of shares. To facilitate the transfer of the Ordinary Shares by the Investor, the Ordinary
 Shares will not bear any restrictive legends so long as there is an effective Registration
 Statement covering the resale of such Ordinary Shares (it being understood and agreed by
 the Investor that notwithstanding the lack of restrictive legends, the Investor may only
 sell such Ordinary Shares pursuant to the Plan of Distribution set forth in the Prospectus
 included in the Registration Statement and otherwise in compliance with the requirements
 of the Securities Act (including any applicable prospectus delivery requirements) or pursuant
 to an available exemption).

&nbsp;&nbsp;&nbsp;&nbsp;(c) On
 or prior to the Advance Date, each of the Company and the Investor shall deliver to the other
 all documents, instruments and writings expressly required to be delivered by either of them
 pursuant to this Agreement in order to implement and effect the transactions contemplated
 herein.

&nbsp;&nbsp;&nbsp;&nbsp;(d) Notwithstanding
 anything to the contrary in this Agreement, if on any day during the Pricing Period (i) the
 Company notifies Investor that a Material Outside Event has occurred, or (ii) the Company
 notifies the Investor of a Black Out Period, the parties agree that the pending Advance shall
 end and the final number of Advance Shares to be purchased by the Investor at the Closing
 for such Advance shall be equal to the number of Ordinary Shares sold by the Investor during
 the applicable Pricing Period prior to the notification from the Company of a Material Outside
 Event or Black Out Period.

Section 2.03 <u>Hardship</u>.

&nbsp;&nbsp;&nbsp;&nbsp;(a) In
 the event the Investor sells Ordinary Shares after receipt of an Advance Notice and the Company
 fails to perform its obligations as mandated in Section 2.02, the Company agrees that in
 addition to and in no way limiting the rights and obligations set forth in Article V hereto
 and in addition to any other remedy to which the Investor is entitled at law or in equity,
 including, without limitation, specific performance, it will hold the Investor harmless against
 any loss, claim, damage, or expense (including reasonable legal fees and expenses), as incurred,
 arising out of or in connection with such default by the Company and acknowledges that irreparable
 damage may occur in the event of any such default. It is accordingly agreed that the Investor
 shall be entitled to an injunction or injunctions to prevent such breaches of this Agreement
 and to specifically enforce (subject to Applicable Laws and the rules of the Principal Market),
 without the posting of a bond or other security, the terms and provisions of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;(b) In
 the event the Company provides an Advance Notice and the Investor fails to perform its obligations
 as mandated in Section 2.02, the Investor agrees that in addition to and in no way limiting
 the rights and obligations set forth in Article V hereto and in addition to any other remedy
 to which the Company is entitled at law or in equity, including, without limitation, specific
 performance, it will hold the Company harmless against any loss, claim, damage, or expense
 (including reasonable legal fees and expenses), as incurred, arising out of or in connection
 with such default by the Investor and acknowledges that irreparable damage may occur in the
 event of any such default. It is accordingly agreed that the Company shall be entitled to
 an injunction or injunctions to prevent such breaches of this Agreement and to specifically
 enforce (subject to the Securities Act and other rules of the Principal Market), without
 the posting of a bond or other security, the terms and provisions of this Agreement.

Section 2.04 <u>Completion of Resale Pursuant to the Registration Statement</u>. After the Investor has purchased the full Commitment Amount and has completed the subsequent resale of the full Commitment Amount pursuant to the Registration Statement, Investor will notify the Company in writing (which may be by e-mail) that all subsequent resales are completed and the Company will be under no further obligation to maintain the effectiveness of the Registration Statement.

**Article III. Representations and Warranties of the Investor**

The Investor represents and warrants to the Company, as of the date hereof, as of each Advance Notice Date and each Advance Date that:

Section 3.01 <u>Organization and Authorization</u>. The Investor is duly organized, validly existing and in good standing under the laws of the Cayman Islands and has the requisite corporate power and authority to enter into and perform its obligations under this Agreement and to purchase or acquire Shares in accordance with the terms hereof. The decision to invest and the execution and delivery of this Agreement by the Investor, the performance by the Investor of its obligations hereunder and the consummation by the Investor of the transactions contemplated hereby have been duly authorized and require no further consent or authorization by the Investor or its sole member. The undersigned has the right, power and authority to execute and deliver this Agreement and all other instruments on behalf of the Investor or its shareholders. This Agreement has been duly executed and delivered by the Investor and, assuming the execution and delivery hereof and acceptance thereof by the Company, will constitute the legal, valid and binding obligations of the Investor, enforceable against the Investor in accordance with its terms.

Section 3.02 <u>Evaluation of Risks</u>. The Investor has such knowledge and experience in financial, tax and business matters as to be capable of evaluating the merits and risks of, and bearing the economic risks entailed by, an investment in the Ordinary Shares of the Company and of protecting its interests in connection with the transactions contemplated hereby. The Investor acknowledges and agrees that its investment in the Company involves a high degree of risk, and that the Investor may lose all or a part of its investment.

Section 3.03 <u>No Legal, Investment or Tax Advice from the Company</u>. The Investor acknowledges that it had the opportunity to review this Agreement and the transactions contemplated by this Agreement with its own legal counsel and investment and tax advisors. The Investor is relying solely on such counsel and advisors and not on any statements or representations of the Company or any of the Company's representatives or agents for legal, tax, investment or other advice with respect to the Investor's acquisition of Ordinary Shares hereunder, the transactions contemplated by this Agreement or the laws of any jurisdiction, and the Investor acknowledges that the Investor may lose all or a part of its investment.

Section 3.04 <u>Investment Purpose</u>. The Investor is acquiring the Ordinary Shares for its own account, for investment purposes and not with a view towards, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered under or exempt from the registration requirements of the Securities Act or any applicable state securities laws; *provided*, *however*, that by making the representations herein, the Investor does not agree, or make any representation or warranty, to hold any of the Shares for any minimum or other specific term and reserves the right to dispose of the Shares at any time in accordance with, or pursuant to, a Registration Statement filed pursuant to this Agreement or an applicable exemption under the Securities Act. The Investor does not presently have any agreement or understanding, directly or indirectly, with any Person to sell or distribute any of the Shares. The Investor acknowledges that it will be disclosed as an "underwriter" and a "selling stockholder" in each Registration Statement and in any Prospectus contained therein to the extent required by applicable law and to the extent the Prospectus is related to the resale of Registrable Securities.

Section 3.05 <u>Accredited Investor</u>. The Investor is an "<u>Accredited Investor</u>" as that term is defined in Rule 501(a)(3) of Regulation D.

Section 3.06 <u>Information</u>. The Investor and its advisors (and its counsel), if any, have been furnished with all materials relating to the business, finances and operations of the Company and information the Investor deemed material to making an informed investment decision which have been requested by the Investor. The Investor and its advisors (and its counsel), if any, have been afforded the opportunity to ask questions of the Company and its management and have received answers to such questions. Neither such inquiries nor any other due diligence investigations conducted by such Investor or its advisors (and its counsel), if any, or its representatives shall modify, amend or affect the Investor's right to rely on the Company's representations and warranties contained in this Agreement. Notwithstanding Section 3.02 and Section 3.03, the Investor acknowledges and agrees (i) that the Company has not made to the Investor, and the Investor acknowledges and agrees it has not relied upon, any representations and warranties of the Company, its employees or any third party other than the representations and warranties of the Company contained in this Agreement, (ii) the Investor understands that its investment involves a high degree of risk, and (iii) the Investor has sought such accounting, legal and tax advice, as it has considered necessary to make an informed investment decision with respect to the transactions contemplated hereby.

Section 3.07 <u>Not an Affiliate</u>. The Investor is not an officer, director or a person that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control with the Company or any "<u>Affiliate</u>" of the Company (as that term is defined in Rule 405 promulgated under the Securities Act). During the Commitment Period, the Investor will not acquire for its own account any Ordinary Shares or securities exercisable for, or convertible into, Ordinary Shares, other than pursuant to this Agreement or pursuant to any transaction entered into directly with the Company.

Section 3.08 <u>No Prior Short Sales</u>. At no time prior to the date of this Agreement has the Investor, its sole member, any of their respective officers, or any entity managed or controlled by the Investor or its sole member, engaged in or effected, in any manner whatsoever, directly or indirectly, for its own principal account, any (i) "short sale" (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of the Ordinary Shares or (ii) hedging transaction, which establishes a net short position with respect to the Ordinary Shares that remains in effect as of the date of this Agreement.

Section 3.09 <u>General Solicitation</u>. Neither the Investor, nor any of its affiliates, nor any person acting on its or their behalf, has engaged or will engage in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with any offer or sale of the Ordinary Shares by the Investor.

Section 3.10 <u>No Conflicts</u>. The execution, delivery and performance by the Investor of this Agreement and the consummation by the Investor of the transactions contemplated hereby do not and shall not (i) result in a violation of such Investor's applicable organizational instruments, (ii) conflict with, constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or give rise to any rights of termination, amendment, acceleration or cancellation of, any material agreement, mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which the Investor is a party or is bound, or (iii) result in a violation of any federal, state, local or foreign statute, rule, or regulation, or any order, judgment or decree of any court or governmental agency applicable to the Investor or by which any of its properties or assets are bound or affected, except, in the case of clauses (ii) and (iii), for such conflicts, defaults, terminations, amendments, acceleration, cancellations and violations as would not, individually or in the aggregate, prohibit or otherwise interfere with, in any material respect, the ability of the Investor to enter into and perform its obligations under this Agreement.

Section 3.11 <u>Reliance on Exemptions</u>. The Investor understands that the Shares are being offered and sold to it in reliance on specific exemptions from the registration requirements of U.S. federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and the Investor's compliance with, the representations, warranties, agreements, acknowledgments and understandings of the Investor set forth herein in order to determine the availability of such exemptions and the eligibility of the Investor to acquire the Shares.

Section 3.12 <u>No Governmental Review</u>. The Investor understands that no United States federal or state agency or any other government or governmental agency has passed on or made any recommendation or endorsement of the Shares or the fairness or suitability of the investment in the Shares nor have such authorities passes upon or endorsed the merits of the offering of the Shares.

Section 3.13 <u>Resale of Shares</u>. The Investor represents, warrants and covenants that it will resell such Shares only pursuant to a Registration Statement in which the resale of such Advance Shares is registered under the Securities Act, in a manner described under the caption "Plan of Distribution" in such Registration Statement, and in a manner in compliance with all applicable U.S. federal and state securities laws, rules and regulations, including, without limitation, any applicable prospectus delivery requirements of the Securities Act.

**Article IV. Representations and Warranties of the Company**

Except as set forth in the SEC Documents, the Company represents and warrants to the Investor that, upon the closing of the Business Combination and each Advance Date (other than representations and warranties which address matters only as of a certain date, which shall be true and correct as written as of such certain date):

Section 4.01 <u>Organization and Qualification</u>. Each of the Company and its Subsidiaries is an entity duly organized and validly existing under the laws of their respective jurisdiction of organization, and has the requisite power and authority to own its properties and to carry on its business as now being conducted. Each of the Company and its Subsidiaries is duly qualified to do business and is in good standing (to the extent applicable) in every jurisdiction in which the nature of the business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified or be in good standing would not have a Material Adverse Effect.

Section 4.02 <u>Authorization, Enforcement, Compliance with Other Instruments.</u> The Company has the requisite corporate power and authority to enter into and perform its obligations under this Agreement and the other Transaction Documents and to issue the Shares in accordance with the terms hereof and thereof. The execution and delivery by the Company of this Agreement and the other Transaction Documents, and the consummation by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Ordinary Shares) have been or (with respect to consummation) will be duly authorized by the Company's board of directors and no further consent or authorization will be required by the Company, its board of directors or its shareholders. This Agreement and the other Transaction Documents to which the Company is a party have been (or, when executed and delivered, will be) duly executed and delivered by the Company and, assuming the execution and delivery thereof and acceptance by the Investor, constitute (or, when duly executed and delivered, will be) the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or other laws relating to, or affecting generally, the enforcement of applicable creditors' rights and remedies and except as rights to indemnification and to contribution may be limited by federal or state securities law. "<u>Transaction Documents</u>" means, collectively, this Agreement and each of the other agreements and instruments entered into or delivered by any of the parties hereto in connection with the transactions contemplated hereby and thereby, as may be amended from time to time.

Section 4.03 <u>Authorization of the Shares</u>. The Shares to be issued under this Agreement have been, or with respect to Shares to be purchased by the Investor pursuant to an Advance Notice, will be, when issued and delivered pursuant to the terms approved by the board of directors of the Company or a duly authorized committee thereof, or a duly authorized executive committee, against payment therefor as provided herein, duly and validly authorized and issued and fully paid and nonassessable, free and clear of any pledge, lien, encumbrance, security interest or other claim, including any statutory or contractual preemptive rights, resale rights, rights of first refusal or other similar rights, and will be registered pursuant to Section 12 of the Exchange Act. The Shares, when issued, will conform to the description thereof set forth in or incorporated into the Prospectus.

Section 4.04 <u>No Conflict</u>. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Ordinary Shares) will not (i) result in a violation of the articles of incorporation or other organizational documents of the Company or its Subsidiaries (with respect to consummation, as the same may be amended prior to the date on which any of the transactions contemplated hereby are consummated), (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Company or its Subsidiaries is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations) applicable to the Company or its Subsidiaries or by which any property or asset of the Company or its Subsidiaries is bound or affected except, in the case of clause (ii) or (iii) above, to the extent such violations that would not reasonably be expected to have a Material Adverse Effect.

Section 4.05 <u>SEC Documents; Financial Statements</u>. Since November 15, 2021, the Company has timely filed (giving effect to permissible extensions in accordance with Rule 12b-25 under the Exchange Act) all reports, schedules, forms, statements and other documents required to be filed by it with the SEC pursuant to the Exchange Act, including, without limitation, the Current Report, each Registration Statement, as the same may be amended from time to time, the Prospectus contained therein and each Prospectus Supplement thereto, and all information contained in such filings and all documents and disclosures that have been or may in the future be incorporated by reference therein (all such documents hereinafter referred to as the "<u>SEC Documents</u>"). The Company has delivered or made available to the Investor through the SEC's website at http://www.sec.gov, true and complete copies of the SEC Documents, as applicable. Except as disclosed in amendments or subsequent filings to the SEC Documents, as of its filing date (or, if amended or superseded by a filing prior to the date hereof, on the date of such amended or superseded filing), each SEC Documents complied in all material respects with the requirements of the Exchange Act or the Securities Act, as applicable, and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and did not contain any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.

Section 4.06 <u>Financial Statements</u>. The consolidated financial statements of the Company included or incorporated by reference in the SEC Documents, together with the related notes and schedules, present fairly, in all material respects, the consolidated financial position of the Company and the Subsidiaries as of the dates indicated and the consolidated results of operations, cash flows and changes in stockholders' equity of the Company for the periods specified and have been prepared in compliance with the requirements of the Securities Act and Exchange Act and in conformity with generally accepted accounting principles in the United States ("<u>GAAP</u>") applied on a consistent basis (except for (i) such adjustments to accounting standards and practices as are noted therein, (ii) in the case of unaudited interim financial statements, to the extent such financial statements may not include footnotes required by GAAP or may be condensed or summary statements and (iii) such adjustments which are not material, either individually or in the aggregate) during the periods involved; the other financial and statistical data with respect to the Company and the Subsidiaries contained or incorporated by reference in the SEC Documents are accurately and fairly presented and prepared on a basis consistent with the financial statements and books and records of the Company; there are no financial statements (historical or pro forma) that are required to be included or incorporated by reference in the SEC Documents that are not included or incorporated by reference as required; the Company and the Subsidiaries do not have any material liabilities or obligations, direct or contingent (including any off-balance sheet obligations), not described in the SEC Documents (excluding the exhibits thereto); and all disclosures contained or incorporated by reference in the SEC Documents regarding "non-GAAP financial measures" (as such term is defined by the rules and regulations of the Commission) comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation S-K under the Securities Act, to the extent applicable. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the SEC Documents fairly presents the information called for in all material respects and has been prepared in accordance with the SEC's rules and guidelines applicable thereto.

Section 4.07 <u>Registration Statement and Prospectus</u>. Each Registration Statement and the offer and sale of Shares as contemplated hereby will meet the requirements of Rule 415 under the Securities Act and comply in all material respects with said Rule. Any statutes, regulations, contracts or other documents that are required to be described in a Registration Statement or a Prospectus, or to be filed as exhibits to a Registration Statement have been so described or filed. Copies of each Registration Statement, any Prospectus, and any such amendments or supplements thereto and all documents incorporated by reference therein that were filed with the Commission on or prior to the date of this Agreement have been delivered, or are available through EDGAR, to the Investor and its counsel. The Company has not distributed and, prior to the later to occur of each Advance Date and completion of the distribution of the Shares, will not distribute any offering material in connection with the offering or sale of the Shares other than a Registration Statement and the Prospectus to which the Investor has consented.

Section 4.08 <u>No Misstatement or Omission</u>. Each Registration Statement, when it became or becomes effective, and any Prospectus, on the date of such Prospectus or amendment or supplement, conformed and will conform in all material respects with the requirements of the Securities Act. At each Advance Date, the Registration Statement and the Prospectus, each as of such date, will conform in all material respects with the requirements of the Securities Act. Each Registration Statement, when it became or becomes effective, did not, and will not, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. Each Prospectus did not, or will not, include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. The documents incorporated by reference in a Prospectus or any Prospectus Supplement did not, and any further documents filed and incorporated by reference therein will not, when filed with the Commission, contain an untrue statement of a material fact or omit to state a material fact required to be stated in such document or necessary to make the statements in such document, in light of the circumstances under which they were made, not misleading. The foregoing shall not apply to statements in, or omissions from, any such document made in reliance upon, and in conformity with, information furnished to the Company by the Investor specifically for use in the preparation thereof.

Section 4.09 <u>Conformity with Securities Act and Exchange Act</u>. Each Registration Statement, each Prospectus, or any amendment or supplement thereto, and the documents incorporated by reference in each Registration Statement, Prospectus or any amendment or supplement thereto, when such documents were or are filed with the SEC under the Securities Act or the Exchange Act or became or become effective under the Securities Act, as the case may be, conformed or will conform in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable.

Section 4.10 <u>Equity Capitalization</u>. On the date of the closing of the Business Combination, the authorized share capital of the Company shall be provided to the Investor as a supplement hereto prior to the Effective Date. From and after the closing of the Business Combination, the Ordinary Shares are registered pursuant to Section 12(b) of the Exchange Act and will be listed on a Principal Market. The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Ordinary Shares under the Exchange Act or delisting the Ordinary Shares from the Principal Market, nor has the Company received any notification that the Commission or the Principal Market is contemplating terminating such registration or listing. To the Company's knowledge, it will be in compliance with all applicable listing requirements of the Principal Market upon the closing of the Business Combination.

Section 4.11 <u>Intellectual Property Rights</u>. The Company and its Subsidiaries own or possess adequate rights or licenses to use all material trademarks, trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and rights, if any, necessary to conduct their respective businesses as now conducted, except as would not cause a Material Adverse Effect. The Company and its Subsidiaries have not received written notice of any infringement by the Company or its Subsidiaries of trademark, trade name rights, patents, patent rights, copyrights, inventions, licenses, service names, service marks, service mark registrations, or trade secrets, except as would not cause a Material Adverse Effect. To the knowledge of the Company, there is no claim, action or proceeding being made or brought against, or to the Company's knowledge, being threatened against the Company or its Subsidiaries regarding trademark, trade name, patents, patent rights, invention, copyright, license, service names, service marks, service mark registrations, trade secret or other infringement except as would not cause a Material Adverse Effect.

Section 4.12 <u>Employee Relations</u>. Neither the Company nor any of its Subsidiaries is involved in any labor dispute nor, to the knowledge of the Company or any of its Subsidiaries, is any such dispute threatened, in each case which is reasonably likely to cause a Material Adverse Effect.

Section 4.13 <u>Environmental Laws</u>. To the Company's knowledge, the Company and its Subsidiaries (i) have not received written notice alleging any failure to comply in all material respects with all Environmental Laws (as defined below), (ii) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii) have not received written notice alleging any failure to comply with all terms and conditions of any such permit, license or approval where, in each of the foregoing clauses (i), (ii) and (iii), the failure to so comply would be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect. The term "<u>Environmental Laws</u>" means all applicable federal, state and local laws relating to pollution or protection of human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata), including, without limitation, laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, "<u>Hazardous Materials</u>") into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations issued, entered, promulgated or approved thereunder.

Section 4.14 <u>Title</u>. Except as would not cause a Material Adverse Effect, the Company (or its Subsidiaries) has indefeasible fee simple or leasehold title to its properties and material assets owned by it, free and clear of any pledge, lien, security interest, encumbrance, claim or equitable interest other than such as are not material to the business of the Company. Any real property and facilities held under lease by the Company and its Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company and its Subsidiaries.

Section 4.15 <u>Insurance</u>. The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the Company and its Subsidiaries are engaged. The Company has no reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not have a Material Adverse Effect.

Section 4.16 <u>Regulatory Permits</u>. Except as would not cause a Material Adverse Effect, the Company and its Subsidiaries possess all material certificates, authorizations and permits issued by the appropriate federal, state or foreign regulatory authorities necessary to own their respective businesses, and neither the Company nor any such Subsidiary has received any written notice of proceedings relating to the revocation or modification of any such certificate, authorization or permits.

Section 4.17 <u>Internal Accounting Controls</u>. The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management's general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management's general or specific authorization and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences, and management is not aware of any material weaknesses that are not disclosed in the SEC Documents as and when required.

Section 4.18 <u>Absence of Litigation</u>. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending against or affecting the Company, the Ordinary Shares or any of the Company's Subsidiaries, wherein an unfavorable decision, ruling or finding would have a Material Adverse Effect.

Section 4.19 <u>Subsidiaries</u>. The Company does not presently own or control, directly or indirectly, any interest in any other corporation, partnership, association or other business entity.

Section 4.20 <u>Tax Status</u>. Each of the Company and its Subsidiaries (i) has timely made or filed all foreign, federal and state income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has timely paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being contested in good faith and (iii) has set aside on its books provision reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply. The Company has not received written notification of any unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company and its Subsidiaries know of no basis for any such claim where failure to pay would cause a Material Adverse Effect.

Section 4.21 <u>Certain Transactions</u>. Except as not required to be disclosed pursuant to Applicable Laws, none of the officers or directors of the Company is presently a party to any transaction with the Company (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer or director, or to the knowledge of the Company, any corporation, partnership, trust or other entity in which any officer or director has a substantial interest or is an officer, director, trustee or partner.

Section 4.22 <u>Rights of First Refusal</u>. The Company is not obligated to offer the Ordinary Shares offered hereunder on a right of first refusal basis to any third parties including, but not limited to, current or former shareholders of the Company, underwriters, brokers, agents or other third parties.

Section 4.23 <u>Dilution</u>. The Company is aware and acknowledges that issuance of Ordinary Shares hereunder could cause dilution to existing shareholders and could significantly increase the outstanding number of Ordinary Shares.

Section 4.24 <u>Acknowledgment Regarding Investor's Purchase of Shares</u>. The Company acknowledges and agrees that the Investor is acting solely in the capacity of an arm's length investor with respect to this Agreement and the transactions contemplated hereunder. The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement and the transactions contemplated hereunder and any advice given by the Investor or any of its representatives or agents in connection with this Agreement and the transactions contemplated hereunder is merely incidental to the Investor's purchase of the Shares hereunder. The Company is aware and acknowledges that it shall not be able to request Advances under this Agreement if a Registration Statement is not effective or if any issuances of Ordinary Shares pursuant to any Advances would violate any rules of the Principal Market. The Company acknowledges and agrees that it is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions of the transactions contemplated by this Agreement.

Section 4.25 <u>Finder's Fees</u>. Neither the Company nor any of the Subsidiaries has incurred any liability for any finder's fees, brokerage commissions or similar payments in connection with the transactions herein contemplated.

Section 4.26 <u>Relationship of the Parties</u>. Neither the Company, nor any of its Subsidiaries, affiliates, or, to the Company's knowledge, any person acting on its or their behalf is a client or customer of the Investor or any of its affiliates and neither the Investor nor any of its affiliates has provided, or will provide, any services to the Company or any of its affiliates, its subsidiaries, or any person acting on its or their behalf. The Investor's relationship to Company is solely as investor as provided for in the Transaction Documents.

Section 4.27 <u>Compliance with Laws</u>. The Company and each of its Subsidiaries are in compliance with Applicable Laws; the Company has not received a notice of non-compliance, nor knows of, nor has reasonable grounds to know of, any facts that any director, officer, or employee of the Company or any Subsidiary nor, to the Company's knowledge, any agent, affiliate or other person acting on behalf of the Company or any Subsidiary has, has not complied with Applicable Laws, or could give rise to a notice of non-compliance with Applicable Laws, and is not aware of any pending change or contemplated change to any applicable law or regulation or governmental position; in each case that would have a Material Adverse Effect.

Section 4.28 <u>Sanctions Matters</u>. Neither the Company nor any of its Subsidiaries or, to the knowledge of the Company, any director, officer or controlled affiliate of the Company or, to the knowledge of the Company, any director or officer of any Subsidiary, is a Person that is, or is owned or controlled by a Person that is (i) the subject of any sanctions administered or enforced by the U.S. Department of Treasury's Office of Foreign Asset Control ("<u>OFAC</u>"), the United Nations Security Council, the European Union, Her Majesty's Treasury, or other relevant sanctions authorities, including, without limitation, designation on OFAC's Specially Designated Nationals and Blocked Persons List or OFAC's Foreign Sanctions Evaders List or other relevant sanctions authority (collectively, "<u>Sanctions</u>"), or (ii) located, organized or resident in a country or territory that is the subject of Sanctions that broadly prohibit dealings with that country or territory (including, without limitation, the Crimea region, the Donetsk People's Republic and Luhansk People's Republic in Ukraine, Cuba, Iran, North Korea, Russia, Sudan and Syria (the "<u>Sanctioned Countries</u>")). Neither the Company nor any of its Subsidiaries will, directly or indirectly, use the proceeds from the sale of Advance Shares, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person (a) for the purpose of funding or facilitating any activities or business of or with any Person or in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions or is a Sanctioned Country, or (b) in any other manner that will result in a violation of Sanctions or Applicable Laws by any Person (including any Person participating in the transactions contemplated by this Agreement, whether as underwriter, advisor, investor or otherwise). For the past five years, neither the Company nor any of its Subsidiaries has engaged in, and is now not engaged in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions or was a Sanctioned Country. Neither the Company nor any of its Subsidiaries nor, to the knowledge of the Company, any director, officer or controlled affiliate of the Company or any of its Subsidiaries, has ever had funds blocked by a United States bank or financial institution, temporarily or otherwise, as a result of OFAC concerns.

**Article V. Indemnification**

The Investor and the Company represent to the other the following with respect to itself:

Section 5.01 <u>Indemnification by the Company</u>. In consideration of the Investor's execution and delivery of this Agreement and acquiring the Shares hereunder, and in addition to all of the Company's other obligations under this Agreement, the Company shall defend, protect, indemnify and hold harmless the Investor and its investment manager, Yorkville Advisors Global, LP, and each of their respective officers, directors, managers, members, partners, employees and agents (including, without limitation, those retained in connection with the transactions contemplated by this Agreement) and each person who controls the Investor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (collectively, the "<u>Investor Indemnitees</u>") from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and reasonable and documented expenses in connection therewith (irrespective of whether any such Investor Indemnitee is a party to the action for which indemnification hereunder is sought), and including reasonable attorneys' fees and disbursements (the "<u>Indemnified Liabilities</u>"), incurred by the Investor Indemnitees or any of them as a result of, or arising out of, or relating to (a) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement for the registration of the Shares as originally filed or in any amendment thereof, or in any related prospectus, or in any amendment thereof or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading; <u>provided</u>, <u>however</u>, that the Company will not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with written information furnished to the Company by or on behalf of the Investor specifically for inclusion therein; (b) any material misrepresentation or breach of any material representation or material warranty made by the Company in this Agreement or any other certificate, instrument or document contemplated hereby or thereby; or (c) any material breach of any material covenant, material agreement or material obligation of the Company contained in this Agreement or any other certificate, instrument or document contemplated hereby or thereby. To the extent that the foregoing undertaking by the Company may be unenforceable under Applicable Law, the Company shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities, which is permissible under Applicable Law.

Section 5.02 <u>Indemnification by the Investor</u>. In consideration of the Company's execution and delivery of this Agreement, and in addition to all of the Investor's other obligations under this Agreement, the Investor shall defend, protect, indemnify and hold harmless the Company and all of its officers, directors, shareholders, employees and agents (including, without limitation, those retained in connection with the transactions contemplated by this Agreement) and each person who controls the Investor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (collectively, the "<u>Company Indemnitees</u>") from and against any and all Indemnified Liabilities incurred by the Company Indemnitees or any of them as a result of, or arising out of, or relating to (a) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement for the registration of the Shares as originally filed or in any amendment thereof, or in any related prospectus, or in any amendment thereof or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading; <u>provided</u>, <u>however</u>, that the Investor will only be liable for written information relating to the Investor furnished to the Company by or on behalf of the Investor specifically for inclusion in the documents referred to in the foregoing indemnity, and will not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with written information furnished to the Investor by or on behalf of the Company specifically for inclusion therein; (b) any misrepresentation or breach of any representation or warranty made by the Investor in this Agreement or any instrument or document contemplated hereby or thereby executed by the Investor; or (c) any breach of any covenant, agreement or obligation of the Investor contained in this Agreement or any other certificate, instrument or document contemplated hereby or thereby executed by the Investor. To the extent that the foregoing undertaking by the Investor may be unenforceable under Applicable Laws, the Investor shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities, which is permissible under Applicable Laws.

Section 5.03 <u>Notice of Claim</u>. Promptly after receipt by an Investor Indemnitee or Company Indemnitee of notice of the commencement of any action or proceeding (including any governmental action or proceeding) involving an Indemnified Liability, such Investor Indemnitee or Company Indemnitee, as applicable, shall, if a claim for an Indemnified Liability in respect thereof is to be made against any indemnifying party under this Article V, deliver to the indemnifying party a written notice of the commencement thereof; but the failure to so notify the indemnifying party will not relieve it of liability under this Article V except to the extent the indemnifying party is prejudiced by such failure. The indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof with counsel mutually reasonably satisfactory to the indemnifying party and the Investor Indemnitee or Company Indemnitee, as the case may be; provided, however, that an Investor Indemnitee or Company Indemnitee shall have the right to retain its own counsel with the actual and reasonable third party fees and expenses of not more than one counsel for such Investor Indemnitee or Company Indemnitee to be paid by the indemnifying party, if, in the reasonable opinion of counsel retained by the indemnifying party, the representation by such counsel of the Investor Indemnitee or Company Indemnitee and the indemnifying party would be inappropriate due to actual or potential differing interests between such Investor Indemnitee or Company Indemnitee and any other party represented by such counsel in such proceeding. The Investor Indemnitee or Company Indemnitee shall cooperate fully with the indemnifying party in connection with any negotiation or defense of any such action or claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the Investor Indemnitee or Company Indemnitee which relates to such action or claim. The indemnifying party shall keep the Investor Indemnitee or Company Indemnitee reasonably apprised as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any settlement of any action, claim or proceeding effected without its prior written consent, provided, however, that the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written consent of the Investor Indemnitee or Company Indemnitee, consent to entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Investor Indemnitee or Company Indemnitee of a release from all liability in respect to such claim or litigation. Following indemnification as provided for hereunder, the indemnifying party shall be subrogated to all rights of the Investor Indemnitee or Company Indemnitee with respect to all third parties, firms or corporations relating to the matter for which indemnification has been made. The indemnification required by this Article V shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received and payment therefor is due.

Section 5.04 <u>Remedies</u>. The remedies provided for in this Article V are not exclusive and shall not limit any right or remedy which may be available to any indemnified person at law or equity. The obligations of the parties to indemnify or make contribution under this Article V shall survive expiration or termination of this Agreement.

Section 5.05 <u>Limitation of liability</u>. Notwithstanding the foregoing, no party shall be entitled to recover from the other party for punitive, indirect, incidental or consequential damages.

**Article VI.<br> Covenants**

The Company covenants with the Investor, and the Investor covenants with the Company, as follows, which covenants of one party are for the benefit of the other party, during the Commitment Period:

Section 6.01 <u>Registration Statement</u>.

&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Filing of a Registration Statement</u>. The Company shall prepare and file with the SEC a Registration
 Statement, or multiple Registration Statements for the resale by the Investor of the Registrable
 Securities. The Company in its sole discretion may choose when to file such Registration
 Statements; *provided, however*, that the Company shall not have the ability to request
 any Advances until the effectiveness of a Registration Statement.

&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Maintaining a Registration Statement</u>. The Company shall maintain the effectiveness of any Registration
 Statement that has been declared effective at all times during the Commitment Period, provided,
 however, that if the Company has received notification pursuant to Section 2.04 that the
 Investor has completed resales pursuant to the Registration Statement for the full Commitment
 Amount, then the Company shall be under no further obligation to maintain the effectiveness
 of the Registration Statement. Notwithstanding anything to the contrary contained in this
 Agreement, the Company shall ensure that, when filed, each Registration Statement (including,
 without limitation, all amendments and supplements thereto) and the prospectus (including,
 without limitation, all amendments and supplements thereto) used in connection with such
 Registration Statement shall not contain any untrue statement of a material fact or omit
 to state a material fact required to be stated therein, or necessary to make the statements
 therein (in the case of prospectuses, in the light of the circumstances in which they were
 made) not misleading. During the Commitment Period, the Company shall notify the Investor
 promptly if (i) the Registration Statement shall cease to be effective under the Securities
 Act, (ii) the Ordinary Shares shall cease to be authorized for listing on the Principal Market,
 (iii) the Ordinary Shares cease to be registered under Section 12(b) or Section 12(g) of
 the Exchange Act or (iv) the Company fails to file in a timely manner all reports and other
 documents required of it as a reporting company under the Exchange Act.

&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Filing Procedures</u>. The Company shall (A) permit counsel to the Investor an opportunity to review
 and comment upon (i) each Registration Statement at least three (3) Trading Days prior to
 its filing with the SEC and (ii) all amendments and supplements to each Registration Statement
 (including, without limitation, the Prospectus contained therein) (except for Annual Reports
 on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and any similar
 or successor reports or Prospectus Supplements the contents of which is limited to that set
 forth in such reports) within a reasonable number of days prior to their filing with the
 SEC, and (B) shall reasonably consider any comments of the Investor and its counsel on any
 such Registration Statement or amendment or supplement thereto or to any Prospectus contained
 therein. The Company shall promptly furnish to the Investor, without charge, (i) electronic
 copies of any correspondence from the SEC or the Staff to the Company or its representatives
 relating to each Registration Statement (which correspondence shall be redacted to exclude
 any material, non-public information regarding the Company or any of its Subsidiaries), (ii)
 after the same is prepared and filed with the SEC, one (1) electronic copy of each Registration
 Statement and any amendment(s) and supplement(s) thereto, including, without limitation,
 financial statements and schedules, all documents incorporated therein by reference, if requested
 by the Investor, and all exhibits and (iii) upon the effectiveness of each Registration Statement,
 one (1) electronic copy of the Prospectus included in such Registration Statement and all
 amendments and supplements thereto; provided, however, the Company shall not be required
 to furnish any document to the extent such document is available on EDGAR).

&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Amendments and Other Filings</u>. The Company shall (i) prepare and file with the SEC such amendments
 (including post-effective amendments) and supplements to a Registration Statement and the
 related prospectus used in connection with such Registration Statement, which prospectus
 is to be filed pursuant to Rule 424 promulgated under the Securities Act, as may be necessary
 to keep such Registration Statement effective at all times during the Commitment Period,
 and prepare and file with the SEC such additional Registration Statements in order to register
 for resale under the Securities Act all of the Registrable Securities; (ii) cause the related
 prospectus to be amended or supplemented by any required prospectus supplement (subject to
 the terms of this Agreement), and as so supplemented or amended to be filed pursuant to Rule
 424 promulgated under the Securities Act; (iii) provide the Investor copies of all correspondence
 from and to the SEC relating to a Registration Statement (provided that the Company may excise
 any information contained therein which would constitute material, non-public information,
 and (iv) comply with the provisions of the Securities Act with respect to the Registration
 Statement. In the case of amendments and supplements to a Registration Statement which are
 required to be filed pursuant to this Agreement (including pursuant to this Section 6.01(d)
 by reason of the Company's filing a report on Form 10-K, Form 10-Q, or Form 8-K or
 any analogous report under the Exchange Act, the Company shall file such report in a prospectus
 supplement filed pursuant to Rule 424 promulgated under the Securities Act to incorporate
 such filing into the Registration Statement, if applicable, or shall file such amendments
 or supplements with the SEC either on the day on which the Exchange Act report is filed which
 created the requirement for the Company to amend or supplement the Registration Statement,
 if feasible, or otherwise promptly thereafter.

&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Blue-Sky</u>.
 The Company shall use its commercially reasonable efforts to, if required by Applicable Laws,
 (i) register and qualify the Ordinary Shares covered by a Registration Statement under such
 other securities or "blue sky" laws of such jurisdictions in the United States
 as the Investor reasonably requests, (ii) prepare and file in those jurisdictions, such amendments
 (including post-effective amendments) and supplements to such registrations and qualifications
 as may be necessary to maintain the effectiveness thereof during the Commitment Period, (iii)
 take such other actions as may be necessary to maintain such registrations and qualifications
 in effect at all times during the Commitment Period, and (iv) take all other actions reasonably
 necessary or advisable to qualify the Ordinary Shares for sale in such jurisdictions; provided,
 however, that the Company shall not be required in connection therewith or as a condition
 thereto to (w) make any change to its articles of incorporation or bylaws or any other organizational
 documents of the Company or any of its Subsidiaries, (x) qualify to do business in any jurisdiction
 where it would not otherwise be required to qualify but for this 0, (y) subject itself to
 general taxation in any such jurisdiction, or (z) file a general consent to service of process
 in any such jurisdiction. The Company shall promptly notify the Investor of the receipt by
 the Company of any notification with respect to the suspension of the registration or qualification
 of any of the Ordinary Shares for sale under the securities or "blue sky" laws
 of any jurisdiction in the United States or its receipt of actual notice of the initiation
 or threat of any proceeding for such purpose.

Section 6.02 <u>Suspension of Registration Statement</u>.

&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Establishment of a Black Out Period</u>. During the Commitment Period, the Company from time to time may
 suspend the use of the Registration Statement by written notice to the Investor in the event
 that the Company determines in its sole discretion in good faith that such suspension is
 necessary to (A) delay the disclosure of material, non-public information concerning the
 Company, the disclosure of which at the time is not, in the good faith opinion of the Company,
 in the best interests of the Company or (B) amend or supplement the Registration Statement
 or Prospectus so that such Registration Statement or Prospectus shall not include an untrue
 statement of a material fact or omit to state a material fact required to be stated therein
 or necessary to make the statements therein, in light of the circumstances under which they
 were made, not misleading (a " <u>Black Out Period</u> ").

&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>No Sales by Investor During the Black Out Period</u>. During such Black Out Period, the Investor
 agrees not to sell any Ordinary Shares of the Company pursuant to such Registration Statement,
 but may sell shares pursuant to an exemption from registration, if available, subject to
 the Investor's compliance with Applicable Laws.

&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Limitations on the Black Out Period</u>. The Company shall not impose any Black Out Period that is longer
 than 30 days or in a manner that is more restrictive (including, without limitation, as to
 duration) than the comparable restrictions that the Company may impose on transfers of the
 Company's equity securities by its directors and senior executive officers. In addition,
 the Company shall not deliver any Advance Notice during any Black Out Period. If the public
 announcement of such material, non-public information is made during a Black Out Period,
 the Black Out Period shall terminate immediately after such announcement, and the Company
 shall immediately notify the Investor of the termination of the Black Out Period.

Section 6.03 <u>Listing of Ordinary Shares</u>. As of each Advance Date, the Shares to be sold by the Company from time to time hereunder will have been registered under Section 12(b) of the Exchange Act and approved for listing on the Principal Market, subject to official notice of issuance.

Section 6.04 <u>Opinion of Counsel</u>. Prior to the date of the delivery by the Company of the first Advance Notice, the Investor shall have received an opinion letter from counsel to the Company in form and substance reasonably satisfactory to the Investor.

Section 6.05 <u>Exchange Act Registration</u>. The Company will file in a timely manner all reports and other documents required of it as a reporting company under the Exchange Act and will not take any action or file any document (whether or not permitted by Exchange Act or the rules thereunder) to terminate or suspend its reporting and filing obligations under the Exchange Act.

Section 6.06 <u>Transfer Agent Instructions</u>. During the Commitment Period (or such shorter time as permitted by Section 2.04 of this Agreement) and subject to Applicable Laws, the Company shall cause (including, if necessary, by causing legal counsel for the Company to deliver an opinion) the transfer agent for the Ordinary Shares to remove restrictive legends from Ordinary Shares purchased by the Investor pursuant to this Agreement, provided that counsel for the Company shall have been furnished with such documents as they may require for the purpose of enabling them to render the opinions or make the statements requested by the transfer agent, or in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the covenants, obligations or conditions, contained herein.

Section 6.07 <u>Corporate Existence</u>. The Company will use commercially reasonable efforts to preserve and continue the corporate existence of the Company during the Commitment Period.

Section 6.08 <u>Notice of Certain Events Affecting Registration; Suspension of Right to Make an Advance</u>. During the Commitment Period, the Company will promptly notify the Investor, and confirm in writing, upon its becoming aware of the occurrence of any of the following events in respect of a Registration Statement or related Prospectus relating to an offering of the Ordinary Shares (in each of which cases the information provided to Investor will be kept strictly confidential): (i) except for requests made in connection with SEC investigations disclosed in the SEC Documents, receipt of any request for additional information by the SEC or any other Federal or state governmental authority during the period of effectiveness of the Registration Statement or any request for amendments or supplements to the Registration Statement or related Prospectus; (ii) the issuance by the SEC or any other Federal governmental authority of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Ordinary Shares for sale in any jurisdiction or the initiation or written threat of any proceeding for such purpose; (iv) the happening of any event that makes any statement made in the Registration Statement or related Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes in the Registration Statement, related Prospectus or documents so that, in the case of the Registration Statement, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading, and that in the case of the related Prospectus, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, or of the necessity to amend the Registration Statement or supplement a related Prospectus to comply with the Securities Act or any other law (and the Company will promptly make available to the Investor any such supplement or amendment to the related Prospectus); (v) the Company's reasonable determination that a post-effective amendment to the Registration Statement would be required under Applicable Law; (vi) the Ordinary Shares shall cease to be authorized for listing on the Principal Market; or (vii) the Company fails to file in a timely manner all reports and other documents required of it as a reporting company under the Exchange Act. The Company shall not deliver to the Investor any Advance Notice, and the Company shall not sell any Shares pursuant to any pending Advance Notice (other than as required pursuant to Section 2.02(d)), during the continuation of any of the foregoing events (each of the events described in the immediately preceding clauses (i) through (vii), inclusive, a "<u>Material Outside Event</u>").

Section 6.09 <u>Consolidation</u>. If an Advance Notice has been delivered to the Investor, then the Company shall not effect any consolidation of the Company with or into, or a transfer of all or substantially all the assets of the Company to another entity before the transaction contemplated in such Advance Notice has been closed in accordance with Section 2.02 hereof, and all Shares in connection with such Advance have been received by the Investor.

Section 6.10 <u>Issuance of the Company's Ordinary Shares.</u> The issuance and sale of the Ordinary Shares hereunder shall be made in accordance with the provisions and requirements of Section 4(a)(2) of the Securities Act and any applicable state securities law.

Section 6.11 <u>Expenses</u>. The Company, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated, will pay all expenses incident to the performance of its obligations hereunder, including but not limited to (i) the preparation, printing and filing of the Registration Statement and each amendment and supplement thereto, of each prospectus and of each amendment and supplement thereto; (ii) the preparation, issuance and delivery of any Shares issued pursuant to this Agreement, (iii) all fees and disbursements of the Company's counsel, accountants and other advisors (but not, for the avoidance doubt, the fees and disbursements of Investor's counsel, accountants and other advisors), (iv) the qualification of the Shares under securities laws in accordance with the provisions of this Agreement, including filing fees in connection therewith, (v) the printing and delivery of copies of any prospectus and any amendments or supplements thereto requested by the Investor, (vi) the fees and expenses incurred in connection with the listing or qualification of the Shares for trading on the Principal Market, or (vii) filing fees of the SEC and the Principal Market.

Section 6.12 <u>Current Report.</u> The Company shall, not later than 5:30 p.m., New York City time, on the fourth business day after the date of this Agreement, file with the SEC a current report on Form 8-K disclosing the execution of this Agreement by the Company and the Investor (including any exhibits thereto, the "<u>Current Report</u>"). The Company shall provide the Investor and its legal counsel a reasonable opportunity to comment on any description of this Agreement contained in a draft of the Current Report, including any exhibit to be filed related thereto, as applicable, prior to filing the Current Report with the SEC and shall give due consideration to all such comments. From and after the filing of the Current Report with the SEC, the Company shall have publicly disclosed all material, non-public information delivered to the Investor (or the Investor's representatives or agents) by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, agents or representatives (if any) in connection with the transactions contemplated by the Transaction Documents. The Company shall not, and the Company shall cause each of its Subsidiaries and each of its and their respective officers, directors, employees and agents not to, provide the Investor with any material, non-public information regarding the Company or any of its Subsidiaries without the express prior written consent of the Investor (which may be granted or withheld in the Investor's sole discretion); it being understood that the mere notification of Investor required pursuant to Section 6.08(iv) hereof shall not in and of itself be deemed to be material, non-public information. Notwithstanding anything contained in this Agreement to the contrary, the Company expressly agrees that it shall publicly disclose in the Current Report or otherwise make publicly available any information communicated to the Investor by or, to the knowledge of the Company, on behalf of the Company in connection with the transactions contemplated herein, which, following the date hereof would, if not so disclosed, constitute material, non-public information regarding the Company or its Subsidiaries. The Company understands and confirms that the Investor will rely on the foregoing representations in effecting resales of Shares under a Registration Statement.

Section 6.13 <u>Advance Notice Limitation</u>. The Company shall not deliver an Advance Notice if a stockholder meeting or corporate action date, or the record date for any stockholder meeting or any corporate action, would fall during the period beginning two (2) Trading Days prior to the date of delivery of such Advance Notice and ending two (2) Trading Days following the Closing of such Advance.

Section 6.14 <u>Use of Proceeds</u>. The proceeds from the sale of the Shares by the Company to Investor shall be used by the Company in the manner as will be set forth in the Prospectus included in any Registration Statement (and any post-effective amendment thereto) and any Prospectus Supplement thereto filed pursuant to this Agreement.

Section 6.15 <u>Compliance with Laws</u>. The Company shall comply in all material respects with all Applicable Laws.

Section 6.16 <u>Market Activities</u>. Neither the Company, nor any Subsidiary, nor any of their respective officers, directors or controlling persons will, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or might reasonably be expected to constitute or result, in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Ordinary Shares or (ii) sell, bid for, or purchase Ordinary Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Shares.

Section 6.17 <u>Trading Information</u>. Upon the Company's request, the Investor agrees to provide the Company with trading reports setting forth the number and average sales prices of shares of Ordinary Shares sold by the Investor during the prior trading week.

Section 6.18 <u>Selling Restrictions</u>. (i) Except as expressly set forth below, the Investor covenants that from and after the date hereof through and including the Trading Day next following the expiration or termination of this Agreement as provided in Section 10.01 (the "<u>Restricted Period</u>"), none of the Investor any of its officers, or any entity managed or controlled by the Investor (collectively, the "<u>Restricted Persons</u>" and each of the foregoing is referred to herein as a "<u>Restricted Person</u>") shall, directly or indirectly, (i) engage in any "short sale" (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of the Ordinary Shares or (ii) engage in any hedging transaction, which establishes a net short position with respect to any securities of the Company (including the Common Shares), with respect to each of clauses (i) and (ii) hereof, either for its own principal account or for the principal account of any other Restricted Person. Notwithstanding the foregoing, it is expressly understood and agreed that nothing contained herein shall (without implication that the contrary would otherwise be true) prohibit any Restricted Person during the Restricted Period from: (1) selling "long" (as defined under Rule 200 promulgated under Regulation SHO) the Shares; or (2) selling a number of Ordinary Shares equal to the number of Advance Shares that such Restricted Person is unconditionally obligated to purchase under a pending Advance Notice but has not yet received from the Company or the transfer agent pursuant to this Agreement.

Section 6.19 <u>Assignment</u>. Neither this Agreement nor any rights or obligations of the parties hereto may be assigned to any other Person.

**Article VII.<br> Conditions for Delivery of Advance Notice**

Section 7.01 <u>Conditions Precedent to the Right of the Company to Deliver an Advance Notice</u>. The right of the Company to deliver an Advance Notice and the obligations of the Investor hereunder with respect to an Advance are subject to the satisfaction or waiver, on each Advance Notice Date (a "<u>Condition Satisfaction Date</u>"), of each of the following conditions:

&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Accuracy of the Company's Representations and Warranties</u>. The representations and warranties
 of the Company in this Agreement shall be true and correct in all material respects.

&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Registration of the Ordinary Shares with the SEC</u>. There is an effective Registration Statement pursuant
 to which the Investor is permitted to utilize the prospectus thereunder to resell all of
 the Ordinary Shares issuable pursuant to such Advance Notice. The Company shall have filed
 with the SEC in a timely manner (giving effect to permissible extensions in accordance with
 Rule 12b-25 under the Exchange Act) all reports, notices and other documents required under
 the Exchange Act and applicable SEC regulations during the twelve month prior immediately
 preceding the applicable Condition Satisfaction Date.

&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Authority</u>.
 The Company shall have obtained all permits and qualifications required by any applicable
 state for the offer and sale of all the Ordinary Shares issuable pursuant to such Advance
 Notice, or shall have the availability of exemptions therefrom. The sale and issuance of
 such Ordinary Shares shall be legally permitted by all laws and regulations to which the
 Company is subject.

&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>No Material Outside Event</u>. No Material Outside Event shall have occurred and be continuing.

&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Performance by the Company</u>. The Company shall have performed, satisfied and complied in all material
 respects with all covenants, agreements and conditions required by this Agreement to be performed,
 satisfied or complied with by the Company at or prior to the applicable Condition Satisfaction
 Date.

&nbsp;&nbsp;&nbsp;&nbsp;(f) <u>No Injunction</u>. No statute, rule, regulation, executive order, decree, ruling or injunction
 shall have been enacted, entered, promulgated or endorsed by any court or governmental authority
 of competent jurisdiction that prohibits or directly, materially and adversely affects any
 of the transactions contemplated by this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;(g) <u>No Suspension of Trading in or Delisting of Ordinary Shares</u>. The Ordinary Shares are quoted
 for trading on the Principal Market and all of the Shares issuable pursuant to such Advance
 Notice will be listed or quoted for trading on the Principal Market. The issuance of Ordinary
 Shares with respect to the applicable Advance Notice will not violate the shareholder approval
 requirements of the Principal Market. The Company shall not have received any written notice
 that is then still pending threatening the continued quotation of the Ordinary Shares on
 the Principal Market.

&nbsp;&nbsp;&nbsp;&nbsp;(h) <u>Authorized</u>.
 There shall be a sufficient number of authorized but unissued and otherwise unreserved Ordinary
 Shares for the issuance of all of the Shares issuable pursuant to such Advance Notice.

&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Executed Advance Notice</u>. The representations contained in the applicable Advance Notice shall
 be true and correct in all material respects as of the applicable Condition Satisfaction
 Date.

&nbsp;&nbsp;&nbsp;&nbsp;(j) <u>Consecutive Advance Notices</u>. Except with respect to the first Advance Notice, the Company shall have
 delivered all Shares relating to all prior Advances.

**Article VIII.<br> Non Exclusive Agreement**

Notwithstanding anything contained herein, this Agreement and the rights awarded to the Investor hereunder are non-exclusive, and the Company may, at any time throughout the term of this Agreement and thereafter, issue and allot, or undertake to issue and allot, any shares and/or securities and/or convertible notes, bonds, debentures, options to acquire shares or other securities and/or other facilities which may be converted into or replaced by Ordinary Shares or other securities of the Company, and to extend, renew and/or recycle any bonds and/or debentures, and/or grant any rights with respect to its existing and/or future share capital.

**Article IX.<br> Choice of Law/Jurisdiction**

This Agreement shall be governed by and interpreted in accordance with the laws of the State of New York without regard to the principles of conflict of laws. The parties further agree that any action between them shall be heard in New York County, New York, and expressly consent to the jurisdiction and venue of the Supreme Court of New York, sitting in New York County, New York and the United States District Court of the Southern District of New York, sitting in New York, New York, for the adjudication of any civil action asserted pursuant to this Agreement.

**Article X. Termination**

Section 10.01 <u>Termination</u>.

&nbsp;&nbsp;&nbsp;&nbsp;(a) Unless
 earlier terminated as provided hereunder, this Agreement shall terminate automatically on
 the earliest of (i) the first day of the month next following the 36-month anniversary of
 the Effective Date, (ii) the date on which the Investor shall have made payment of Advances
 pursuant to this Agreement for Ordinary Shares equal to the Commitment Amount, (iii) the
 termination of the Business Combination Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 Company may terminate this Agreement effective upon five Trading Days' prior written
 notice to the Investor; provided that (i) there are no outstanding Advance Notices, the Ordinary
 Shares under which have yet to be issued, and (ii) the Company has paid all amounts owed
 to the Investor pursuant to this Agreement. This Agreement may be terminated at any time
 by the mutual written consent of the parties, effective as of the date of such mutual written
 consent unless otherwise provided in such written consent.

&nbsp;&nbsp;&nbsp;&nbsp;(c) Nothing
 in this Section 10.01 shall be deemed to release the Company or the Investor from any liability
 for any breach under this Agreement, or to impair the rights of the Company and the Investor
 to compel specific performance by the other party of its obligations under this Agreement.
 Section 12.06 and the indemnification provisions contained in Article V shall survive termination
 hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;(d) Notwithstanding
 anything to the contrary in this Agreement, no obligation, including the obligation to issue
 to the Investor the Commitment Shares, shall arise until the consummation of the Business
 Combination. If the Business Combination Agreement is terminated, other than in connection
 with the consummation of the Business Combination, then this Agreement shall be terminated
 and of no further effect, without any liability of any party hereunder.

**Article XI. Notices**

Other than with respect to Advance Notices, which must be in writing and will be deemed delivered on the day set forth in Section 2.01(b), any notices, consents, waivers, or other communications required or permitted to be given under the terms of this Agreement must be in writing and will be deemed to have been delivered (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by e-mail if sent on a Trading Day, or, if not sent on a Trading Day, on the immediately following Trading Day; (iii) five (5) calendar days after being sent by U.S. certified mail, return receipt requested, (iv) one (1) calendar day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The addresses for such communications (except for Advance Notices which shall be delivered in accordance with Exhibit A hereof) shall be:

---

| | |
|:---|:---|
| If to the Company prior to the consummation of the Business Combination, to: | Energem Corp.<br> Level 10, Tower 11, Avenue 5, No. 8<br> Jalan Kerinchi, Bangsar South<br> 59200 Wilayah Persenutuan<br> Kuala Lumpur, Malaysia |
|  | Attention: Doris Wong |
|  | Telephone: 60 12 2237 897<br> Email: Doris@energemcorp.com |

---

---

| | |
|:---|:---|
| With a Copy (which shall not constitute notice or delivery of process) to: | Rimon, P.C.<br> 1717 K Street, NW<br> Suite 900<br> Washington, DC 20006<br>Attention: Debbie A. Klis |
|  | Telephone: (202) 935-3390 |
|  | Email: deborrah.klis@rimonlaw.com |
| If to the Company following the consummation of the Business Combination, to: | Graphjet Technology, Inc.<br> L4-E-8 Enterprise 4<br> Technology Park Malaysia<br> Bukit Jalil 57000<br> Kuala Lumpur, Malaysia |
|  | Attention: Aiden Lee |
|  | Telephone: 60 18 272 7799 |
|  | Email: aidenlee@graphjettech.com |
| With a Copy (which shall not constitute notice or delivery of process) to: | Nelson Mullins Riley & Scarborough LLP<br> 101 Constitution Avenue, NW<br> Suite 900<br> Washington, DC 20001 |

---

---

| | | |
|:---|:---|:---|
|  | Attention: Andrew M. Tucker | Attention: Andrew M. Tucker |
|  | Telephone: (202) 689-2987 | Telephone: (202) 689-2987 |
|  | Email:andy.tucker@nelsonmullins.com | Email:andy.tucker@nelsonmullins.com |
|  | YA II PN, Ltd. | YA II PN, Ltd. |
|  | 1012 Springfield Avenue | 1012 Springfield Avenue |
| If to the Investor(s): | Mountainside, NJ 07092 | Mountainside, NJ 07092 |
|  | Attention: | Mark Angelo |
|  |  | Portfolio Manager |
|  | Telephone: | (201) 985-8300 |
|  | Email: mangelo@yorkvilleadvisors.com | Email: mangelo@yorkvilleadvisors.com |
|  | David Fine, Esq.<br> 1012 Springfield Avenue<br> Mountainside, NJ 07092 | David Fine, Esq.<br> 1012 Springfield Avenue<br> Mountainside, NJ 07092 |
|  | Telephone: | (201) 985-8300 |
| With a Copy (which shall not constitute notice or delivery of process) to: | Email: | legal@yorkvilleadvisors.com |

---

or at such other address and/or e-mail and/or to the attention of such other person as the recipient party has specified by written notice given to each other party prior to the effectiveness of such change. Written confirmation of receipt (i) given by the recipient of such notice, consent, waiver or other communication, (ii) electronically generated by the sender's email service provider containing the time, date, and recipient email address or (iii) provided by a nationally recognized overnight delivery service shall be rebuttable evidence of personal service in accordance with clause (i), (ii) or (iii) above, respectively.

**Article XII. Miscellaneous**

Section 12.01 <u>Counterparts</u>. This Agreement may be executed in identical counterparts, both which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. Facsimile or other electronically scanned and delivered signatures (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, *e.g.*, www.docusign.com), including by e-mail attachment, shall be deemed to have been duly and validly delivered and be valid and effective for all purposes of this Agreement.

Section 12.02 <u>Entire Agreement; Amendments</u>. This Agreement supersedes all other prior oral or written agreements between the Investor, the Company, their respective affiliates and persons acting on their behalf with respect to the matters discussed herein, and this Agreement contains the entire understanding of the parties with respect to the matters covered herein and, except as specifically set forth herein, neither the Company nor the Investor makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may be waived or amended other than by an instrument in writing signed by the parties to this Agreement.

Section 12.03 <u>Reporting Entity for the Ordinary Shares</u>. The reporting entity relied upon for the determination of the trading price or trading volume of the Ordinary Shares on any given Trading Day for the purposes of this Agreement shall be Bloomberg, L.P. or any successor thereto. The written mutual consent of the Investor and the Company shall be required to employ any other reporting entity.

Section 12.04 <u>Commitment and Structuring Fee</u>. Each of the parties shall pay its own fees and expenses (including the fees of any attorneys, accountants, appraisers or others engaged by such party) in connection with this Agreement and the transactions contemplated hereby, except that (i) Graphjet, on behalf of the Company shall pay to YA Global II SPV, LLC, a subsidiary of the Investor, a structuring fee in the amount of $10,000 which shall be paid within five days from the date hereof, and (ii) subject to the consummation of the Business Combination, the Company shall pay a commitment fee in an amount equal to 0.25% of the Commitment Amount (the "<u>Commitment Fee</u>"), which at the option of the Company, the Company may pay (i) by the issuance of Common Shares (collectively, the "<u>Commitment Shares</u>") to the Investor in two installments as follows: (a) on the Effective Date the Company shall issue to the Investor such number of Common Shares that is equal to one half of the Commitment Fee divided by the average of the daily VWAPs of the Ordinary Shares during the 5 Trading Days prior to the Effective Date, and (b) on the 6-month anniversary of the Effective Date the Company shall issue to the Investor such number of Ordinary Shares that is equal to one half of the Commitment Fee divided by the average of the daily VWAPs of the Ordinary Shares during the 5 Trading Days prior to the 6-month anniversary of the Effective Date; or (ii) in cash by wire transfer to the Investor in 2 equal installments on the Effective Date and on the 6-month anniversary of the Effective Date.

Section 12.05 <u>Brokerage</u>. Each of the parties hereto represents that it has had no dealings in connection with this transaction with any finder or broker who will demand payment of any fee or commission from the other party. The Company on the one hand, and the Investor, on the other hand, agree to indemnify the other against and hold the other harmless from any and all liabilities to any person claiming brokerage commissions or finder's fees on account of services purported to have been rendered on behalf of the indemnifying party in connection with this Agreement or the transactions contemplated hereby.

Section 12.06 <u>Trust Fund Waiver</u>. Notwithstanding anything else in this Agreement, the Investor acknowledges that it has read the Company's prospectus dated November 15, 2021, and understands that the Company has established a trust account at J.P. Morgan Securities LLC (the "<u>Trust Fund</u>") for the benefit of the Company's public shareholders and that the Company may disburse monies from the Trust Fund only (a) to the Company's public shareholders in the event they elect to convert their ordinary shares into cash in accordance with the Company's amended and restated memorandum and articles of association and/or the liquidation of the Company or (b) to the Company after, or concurrently with, the consummation of a business combination. The Investor further acknowledges that, if the transactions contemplated by the Business Combination Agreement, or, upon termination of the Business Combination Agreement, another business combination, are not consummated by August 18, 2023, or such later date as shall be set forth in an amendment to the Company's amended and restated memorandum and articles of association for the purpose of extending the date by which the Company must complete a business combination, the Company will be obligated to return to its shareholders the amounts being held in the Trust Fund. Accordingly, the Investor, on behalf of itself and its Affiliates, hereby waives all rights, title, interest or claim of any kind against the Company to collect from the Trust Fund any monies that may be owed to them by the Company for any reason whatsoever, including but not limited to a breach of this Agreement by the Company or any negotiations, agreements or understandings with the Company (whether in the past, present or future), and will not seek recourse against the Trust Fund at any time for any reason whatsoever. This paragraph will survive the termination of this Agreement for any reason, but, notwithstanding anything set forth herein, will not limit the rights of the Company or its shareholders at or following the date of the closing of the Business Combination.

**[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]**

**IN WITNESS WHEREOF**, the parties hereto have caused this Standby Equity Purchase Agreement to be executed by the undersigned, thereunto duly authorized, as of the date first set forth above.

---

| | |
|:---|:---|
| **COMPANY:** | **COMPANY:** |
| **Energem Corp.** | **Energem Corp.** |
| By: | */s/ Hoo Swee Guan* |
| Name: | HOO SWEE GUAN |
| Title: | CEO |
| **Graphjet Technology SDN. BHD.** | **Graphjet Technology SDN. BHD.** |
| By: | */s/ Lee Ping Wei* |
| Name: | LEE PING WEI |
| Title: | CEO |
| **INVESTOR:** | **INVESTOR:** |
| **YA II PN, Ltd.** | **YA II PN, Ltd.** |
| By: | Yorkville Advisors Global, LP |
| Its: | Investment Manager |
| By: | Yorkville Advisors Global II, LLC |
| Its: | General Partner |
| By: | */s/ Matt Beckman* |
| Name: | Matt Beckman |
| Title: | Member |

---

**EXHIBIT A<br> ADVANCE NOTICE**

**[Graphjet Technology]**

---

| | |
|:---|:---|
| **Dated: ______________** | **Advance Notice Number: ____** |

---

The undersigned, _______________________, hereby certifies, with respect to the sale of Ordinary Shares of [_____________________] (the "<u>Company</u>") issuable in connection with this Advance Notice, delivered pursuant to that certain Standby Equity Purchase Agreement, dated as of December __, 2022 (the "<u>Agreement</u>"), as follows (with capitalized terms used herein without definition having the same meanings as given to them in the Agreement):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The undersigned is the duly elected ______________ of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. There are no fundamental changes to the information set forth in the Registration Statement which would require the Company to file a post-effective amendment to the Registration Statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. The Company has performed in all material respects all covenants and agreements to be performed by the Company contained in this Agreement on or prior to the Advance Notice Date. All conditions to the delivery of this Advance Notice are satisfied as of the date hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The number of Advance Shares the Company is requesting is _____________________.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The Pricing Period for this Advance shall be an [Option 1 Pricing Period]/[Option 2 Pricing Period]

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. The Minimum Acceptable Price with respect to this Advance Notice is____________ (if left blank then no Minimum Acceptable Price will be applicable to this Advance). [Only applicable for an Option 2 Pricing Period]

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. The number of Ordinary Shares of the Company outstanding as of the date hereof is ___________.

The undersigned has executed this Advance Notice as of the date first set forth above.

---

| |
|:---|
| **[______________________]** |
| By: |

---

**EXHIBIT B**

**FORM OF SETTLEMENT DOCUMENT**

**<u>VIA EMAIL</u>**

[________________] Attn:

Email:

---

| | |
|:---|:---|
| | Below please find the settlement information with respect to the Advance Notice Date of: |
| 1. | Number of Ordinary Shares requested in the Advance Notice |
| 1.b. | Volume Threshold (Number of Ordinary Shares in (1) divided by 0.20 |
| 1.c. | Number of Ordinary Shares traded during Pricing Period |
| 2. | Minimum Acceptable Price for this Advance (if any) |
| 3. | Number of Excluded Days (if any) |
| 4. | Adjusted Advance Amount (if applicable) (including pursuant to Section 2.01(c)(iv)) |
| 5. | Option [1] / [2] Market Price |
| 6. | Purchase Price (applicable Market Price x 97%/96%) per share |
| 7. | Number of Advance Shares due to the Investor |
| 8. | Total Purchase Price due to Company (row 6 x row 7) |

---

***<u>If there were any Excluded Days then add the following (see Section 2.01(d)</u>***

9. Number
 of Additional Shares to be issued to the Investor

10. Additional
 amount to be paid to the Company by the Investor (Additional Shares in row 9 x Minimum Acceptable Price x 97%)

11. Total
 Amount to be paid to the Company (Purchase Price in row 8 + additional amount in row 10)

12. Total
 Advance Shares to be issued to the Investor (Advance Shares due to the Investor in row 7 + Additional Shares in row 9)

**Please issue the number of Advance Shares due to the Investor to the account of the Investor as follows:**

**Investor's DTC participant #** **:**

**ACCOUNT NAME**:

**ACCOUNT NUMBER**:

**ADDRESS**:

**CITY**:

**COUNTRY**:

**Contact person**:

**Number and/or email**:

---

| | |
|:---|:---|
|  | **Sincerely,** |
|  | **YA II PN, LTD.** |
| **Agreed and approved By: [________________]:** |  |
| **Name:** |  |
| **Title:** |  |

---

## Exhibit 99.1

**Exhibit 99.1**

**Energem Corp. Secures Standby Equity Purchase Agreement with Yorkville Advisors Global, LP**

**New York, New York – January 17, 2023 –** Energem Corp. ("Energem") (Nasdaq: ENCP, ENCPW), a special purpose acquisition company, today announced that it has entered into a definitive $200 million Standby Equity Purchase Agreement ("SEPA") with YA II PN, Ltd., a Cayman Islands exempt limited partnership managed by Yorkville Advisors Global, LP (the "Investor"), and Graphjet Technology Sdn. Bhd., a Malaysian private limited company and pioneering leader in the production of innovative, green, and low-cost graphene, graphite and graphene-based materials ("Graphjet").

As previously announced, Energem and Graphjet entered into a definitive share purchase agreement that will result in Graphjet becoming a wholly-owned subsidiary of Energem, and Energem to be renamed Graphjet Technology and is expected to be listed on the Nasdaq Global Market under the ticker symbol "GTI" (the "Business Combination"). Completion of the announced Business Combination remains subject to clearance by the Securities and Exchange Commission of Energem's Form S-4 and approval by shareholders of both Energem and Graphjet.

Under the terms of the SEPA, and subject to the Closing of the Business Combination, Graphjet Technology will have the right, but not the obligation, in its sole discretion, to issue and sell to the Investor up to $200 million in Graphjet Technology's ordinary shares, based on its funding requirement at any time during the 36 months and the effectiveness of a registration statement with the Securities and Exchange Commission registering Graphjet Technology's ordinary shares issuable pursuant to the SEPA and other terms and customary conditions set forth in the SEPA.

Mr. Swee Guan Hoo, CEO of Energem, commented, "We are pleased to announce this equity investment with Yorkville Advisor Global. This investment is a result of the hard work of our respective teams over the past several months. We thank Yorkville for its support and commitment to Graphjet Technology. Today, we are taking another important step in our venture, positioning Graphjet Technology to meet the demands of its customers, drive growth and secure its path for the future."

Lee Ping Wei, CEO of Graphjet added, "The access to up to $200 million of equity investment under the SEPA is a significant step towards accelerating growth and constructing a state-of-the-art manufacturing facility in the face of persistent demand for graphite, which is the largest component of the lithium-ion battery with about half of a lithium-ion battery comprised of graphite. Graphite is the key raw material in the battery anode with almost all EV battery anodes comprising 100% graphite. As such, graphene based anode battery materials are critical and important in the world of EVs."

Rimon P.C. represented Energem on the SEPA and Nelson Mullins Riley & Scarborough LLP acted as legal counsel to Graphjet.

**About Graphjet Technology Sdn. Bhd.**

Graphjet Technology Sdn. Bhd. was founded in 2019 in Malaysia as an innovative graphene and graphite producer. Graphjet Technology has the world's first patented technology to recycle palm kernel shells generated in the production of palm seed oil to produce single layer graphene and artificial graphite. Graphjet's sustainable production methods utilizing palm kernel shells, a waste agricultural product that is common in Malaysia, will set a new shift in Graphite and Graphene supply chain of the world.

**About Energem Corp.**

Energem Corp. is a blank check company formed for the purposes of effecting a merger, capital share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more energy and/or sustainable natural resource companies. In November 2021, Energem consummated a $115 million initial public offering of 11.5 million units (reflecting the underwriters' full exercise of their over-allotment option), each unit consists of one Class A ordinary share and one redeemable warrant, each warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share. ARC Group Limited acted as sole financial advisor and EF Hutton, division of Benchmark Investments LLC, served as the sole book-running manager of Energem's initial public offering.

**Important Information About the Proposed Business Combination and Where to Find It**

Energem has filed a registration statement on Form F-4 with the SEC, which will include a proxy statement/prospectus, and will file other documents regarding the proposed transaction with the SEC. Energem's shareholders and other interested persons are advised to read, when available, the preliminary proxy statement/prospectus and the amendments thereto and the definitive proxy statement and documents incorporated by reference therein filed in connection with the proposed business combination, as these materials will contain important information about Graphjet and Energem and the proposed business combination. Promptly after the Form F-4 is declared effective by the SEC, Energem will mail the definitive proxy statement/prospectus and a proxy card to each shareholder entitled to vote at the meeting relating to the approval of the business combination and other proposals set forth in the proxy statement/prospectus. **Before making any voting or investment decision, investors and shareholders of Energem are urged to carefully read the entire registration statement and proxy statement/prospectus, when they become available, and any other relevant documents filed with the SEC, as well as any amendments or supplements to these documents, because they will contain important information about the proposed transaction**. The documents filed by Energem with the SEC may be obtained free of charge at the SEC's website at www.sec.gov, or by directing a request to Energem Corp., Level 3, Tower 11, Avenue 5, No. 8, Jalan Kerinchi, Bangsar South, Wilayah Persekutuan, Kuala Lumpur, Malaysia.

**Participants in the Solicitation**

Energem Corp. and certain of its directors, executive officers and other members of management and employees may, under SEC rules, be deemed to be participants in the solicitation of proxies from Energem's shareholders in connection with the proposed transaction. A list of the names of those directors and executive officers and a description of their interests in Energem will be included in the proxy statement/prospectus for the proposed business combination when available at www.sec.gov. Information about Energem's directors and executive officers and their ownership of Energem ordinary shares is set forth in Energem's final prospectus dated November 15, 2021 and filed with the SEC on November 17, 2021, as modified or supplemented by any Form 3 or Form 4 filed with the SEC since the date of such filing. Other information regarding the interests of the participants in the proxy solicitation will be included in the proxy statement/prospectus pertaining to the proposed business combination when it becomes available. These documents can be obtained free of charge from the source indicated above.

Graphjet Technology Sdn. Bhd. and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the shareholders of Energem in connection with the proposed business combination. A list of the names of such directors and executive officers and information regarding their interests in the proposed business combination will be included in the proxy statement/prospectus for the proposed business combination.

Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests is included in the proxy statement/prospectus filed with the SEC on Form F-4. Shareholders, potential investors and other interested persons should read the proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from the sources indicated above.

**Cautionary Statement Regarding Forward-Looking Statements**

This press release may include, and oral statements made from time to time by representatives of Energem may include, "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, Energem's management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in Energem's filings with the Securities and Exchange Commission ("SEC"). All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Energem, including those set forth in the Risk Factors section of Energem's registration statement and prospectus for Energem's initial public offering filed with the SEC, Energem's Annual Report on Form 10-K for the fiscal year ended December 31, 2021, Energem's Quarterly Reports on Form 10-Q and other filings with the SEC. Energem undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

**No Offer or Solicitation**

This press release relates to a proposed business combination between Energem Corp. and Graphjet Technology Sdn. Bhd., and does not constitute a proxy statement or solicitation of a proxy and does not constitute an offer to sell or a solicitation of an offer to buy the securities of Energem Corp. or Graphjet, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

**Contacts**

Energem Corp.

Level 3, Tower 11, Avenue 5, No. 8,

Jalan Kerinchi, Bangsar South

Wilayah Persekutuan, Kuala Lumpur, Malaysia

Attn: Mr. Swee Guan Hoo

Chief Executive Officer

Tel: + (60) 3270 47622